Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2023 Oct 11;19(10):e1010905. doi: 10.1371/journal.pgen.1010905

Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses

Kevin Emmerich 1,2,#, Steven L Walker 3,¤a,#, Guohua Wang 1,¤b,#, David T White 1, Anneliese Ceisel 1, Fang Wang 1, Yong Teng 4, Zeeshaan Chunawala 1, Gianna Graziano 1, Saumya Nimmagadda 1, Meera T Saxena 1, Jiang Qian 1, Jeff S Mumm 1,2,3,5,*
Editor: Gregory S Barsh6
PMCID: PMC10593236  PMID: 37819938

Abstract

Retinal Müller glia (MG) can act as stem-like cells to generate new neurons in both zebrafish and mice. In zebrafish, retinal regeneration is innate and robust, resulting in the replacement of lost neurons and restoration of visual function. In mice, exogenous stimulation of MG is required to reveal a dormant and, to date, limited regenerative capacity. Zebrafish studies have been key in revealing factors that promote regenerative responses in the mammalian eye. Increased understanding of how the regenerative potential of MG is regulated in zebrafish may therefore aid efforts to promote retinal repair therapeutically. Developmental signaling pathways are known to coordinate regeneration following widespread retinal cell loss. In contrast, less is known about how regeneration is regulated in the context of retinal degenerative disease, i.e., following the loss of specific retinal cell types. To address this knowledge gap, we compared transcriptomic responses underlying regeneration following targeted loss of rod photoreceptors or bipolar cells. In total, 2,531 differentially expressed genes (DEGs) were identified, with the majority being paradigm specific, including during early MG activation phases, suggesting the nature of the injury/cell loss informs the regenerative process from initiation onward. For example, early modulation of Notch signaling was implicated in the rod but not bipolar cell ablation paradigm and components of JAK/STAT signaling were implicated in both paradigms. To examine candidate gene roles in rod cell regeneration, including several immune-related factors, CRISPR/Cas9 was used to create G0 mutant larvae (i.e., “crispants”). Rod cell regeneration was inhibited in stat3 crispants, while mutating stat5a/b, c7b and txn accelerated rod regeneration kinetics. These data support emerging evidence that discrete responses follow from selective retinal cell loss and that the immune system plays a key role in regulating “fate-biased” regenerative processes.

Author summary

Blinding diseases are linked to the loss of specific types of neurons in the retina. In humans, this eventually leads to loss of sight. In zebrafish, however, lost retinal neurons are regenerated resulting in restored vision. Our lab has developed zebrafish models that induce the loss of disease-relevant retinal neurons, thereby allowing us to study how individual cell types are regenerated. Here, to better understand how these processes are regulated, we compared gene expression changes occurring during loss and regeneration of two different retinal cell types, rod photoreceptors and bipolar interneurons. The majority of gene changes were specific to each cell type studied, providing strong evidence that genetic programs underlying stem cell activation vary depending on the cell type lost. We also found that the immune system was implicated as a regulator of regeneration in both models, but that individual immune-related genes were more strongly associated with one of the two models. Furthermore, disrupting multiple genes involved in immune system signaling led to enhanced rod regeneration. We hope that a better understanding of how retinal cell regeneration is regulated in zebrafish will aid efforts to develop regenerative therapeutics designed to restore sight to patients who have lost their vision.

Introduction

Regenerative therapeutics aimed at replacing lost retinal cells have the potential to restore visual function. One category of therapeutics in development aims to stimulate endogenous retinal Müller glia (MG) to act as stem-like cells to replace lost neurons [1,2]. The capacity of MG to drive retinal repair differs markedly between species. In mammals, MG regenerative potential is intact but remains dormant unless exogenously stimulated. In contrast, zebrafish MG robustly regenerate lost retinal neurons [3]. Zebrafish are therefore an established model for exploring mechanisms controlling MG regenerative potential, including factors that enhance the regenerative potential of mammalian MG [48]. Studies of the mechanisms regulating regeneration following widespread retinal cell loss, e.g., damage across multiple cell types/nuclear layers, have focused largely on the role of known developmental pathways and reprogramming factors [3,912]. In contrast, mechanisms governing responses to the loss of specific neuronal types are less well defined. Intriguingly, recent studies in zebrafish suggest that the loss of discrete retinal cell types elicits a fate-biased regenerative response; i.e., where progenitors cells give rise predominantly to the lost cell type [1316]. A deeper understanding of the mechanisms controlling fate-biased regeneration has the potential to facilitate the development of novel cell-type targeted regenerative therapeutic strategies.

Retinal regenerative research in fish has utilized three main injury paradigms: light-induced ablation [1720], toxin-induced ablation [21,22] and mechanical wounding [23,24]. Early mechanical wounding studies involved surgical excisions of retinal quadrants which induce classic hallmarks of epimorphic regeneration: rapid wound closure and the formation of blastema-like zones of proliferative cells [23]. Other paradigms eliminate all or most cells in a retinal somal layer, e.g., light-induced ablation of rod and cone photoreceptor cells in the outer nuclear layer (ONL) [1720], excitotoxin-induced ablation of interneurons in the inner nuclear layer (INL) and retinal ganglion cells (RGCs) [21,22]. Collectively, these studies have identified two injury-inducible stem cell niches in the teleost retina; ONL precursors committed to producing rod cells [25,26], and an INL-localized retinal stem cell [27,28]. Subsequent studies demonstrated that the INL stem cells were Müller glia (MG), which function as injury-induced multipotent stem-like cells. These cells can divide asymmetrically giving rise to a transit-amplifying pool of retinal progenitor cells that then differentiate to regenerate the lost retinal cells [3,911]. Intriguingly, mammalian MG can also produce new neurons upon exogenous expression of neurogenic factors, such as achaete-scute family bHLH transcription factor 1 (ascl1) [4,5] or inhibition of factors such as nuclear factor I a/b/x (nfia/b/x), which function to sustain MG identity [29]. However, the types of neurons produced by mammalian MG are not typically well correlated to types of cells lost; for instance, ascl1 overexpression is largely limited to the production of bipolar cells [5]. More recently, combinatorial application of exogenous neurogenic factors have overcome this limitation to produce ganglion-like cells capable of responding to light [7]. These studies highlight the need to better understand the regulation of MG regenerative potential, and fate choices of MG-derived neural progenitors, are regulated.

Retinal degenerative diseases typically involve the loss of discrete neural cell types. Prominent examples of this include rod photoreceptor loss in retinitis pigmentosa and RGC loss in glaucoma [30,31]. Thus, methods for replacing specific cell types are being sought as a strategy to restore vison to patients. To study how discrete cell types are regenerated we adapted a targeted cell ablation method, the nitroreductase (NTR) prodrug converting enzyme system [3236], to zebrafish [3742]. Transgenic expression of NTR renders cells susceptible to prodrugs, such as metronidazole (Mtz). Exposing fish to Mtz results in the selective loss of NTR-expressing cells by a DNA-damage induced cell death process [4144]. Co-expression of a fluorescent reporter in NTR-targeted cells allows the regenerative process to be characterized in detail using in vivo time-lapse imaging [39,45] or quantified using high-throughput screening methods [40,46]. This approach affords key advantages to the investigation of cellular regeneration. For instance, it can be genetically targeted to individual cell types and is prodrug inducible, allowing temporal synchronization of the regenerative process across many samples. While several mutant zebrafish lines exhibit cell-type specific losses, the lack of control over the onset and duration of cell death make it more difficult to profile regenerative responses in these models. Additionally, several retinal degeneration mutants also fail to regenerate [47] suggesting that a threshold of cell death is required to trigger retinal regeneration. Using this approach, recent studies have shown that selective retinal cell loss elicits a fate-biased regenerative response [1316], although subtler fate-biases have also recently been acknowledged in widespread injury paradigms as well. This suggests limited/selective retinal cell loss and widespread/non-selective retinal injury may trigger regenerative processes that are differentially regulated.

Here, to increase understanding of fate-biased regenerative processes, we used time-resolved gene expression profiling to compare two retinal cell-type specific ablation paradigms in zebrafish. Comparisons between the targeted loss of either 1) bipolar cells [45], or 2) rod photoreceptors [46] involved profiling gene expression changes across 12 timepoints spanning the entire degenerative and regenerative processes. Differential gene expression analysis across a total of 138 microarrays revealed both shared and paradigm-specific profiles. Paradigm-specific expression changes predominated at early and late time points, and shared expression profiles peaked at 24 and 32 hours after induction of cell loss. While paradigm-specific mechanisms were expected to be prevalent during late phases that correspond to progenitor cell differentiation, predominance at early time points suggests that initial retinal stem cell activation involves signals that may be informative regarding cell type lost, thus facilitating fate-biased responses. Finally, genetic disruption of multiple immune-related genes was found to inhibit or enhance rod regeneration kinetics in crispant larvae. This information regarding fate-biased regeneration and immune system modulation could enable the development of cell-type specific regenerative therapeutics for the mammalian retina.

Results

Specificity of NTR/Mtz-induced cell death and assessments of regeneration

To expand our understanding of mechanisms regulating the regeneration of discrete retinal cell types, gene expression changes attending two cell-specific ablation paradigms were compared. Specifically, transgenic zebrafish lines expressing NTR-reporter fusions in either a bipolar interneuron subtype (nyctalopin or nyx-expressing) or rod photoreceptor cells were used, referred to hereafter as “NTR-bipolar” [45] and “NTR-rod” [46], respectively (see Methods for full description). We first confirmed that NTR expression was specific to the targeted cell types within the retina. Prior studies have shown that expression in the NTR-bipolar line is restricted to retinal bipolar cells, with labeling of the pineal gland (epiphysis) in the brain as well [45, 48]. For the NTR-rod line, immunohistochemistry confirmed that expression of the NTR-YFP fusion protein was restricted to rod cells, as previously shown for this line [41] and corresponding promoter element [49]. NTR-YFP expressing cells were co-labeled with a rod-specific antibody marking outer segments, zpr-3 [50, 51](S1a–S1a” Fig), and interdigitated with cells marked by a cone-specific antibody, zpr-1 [52] (S1b–S1b” Fig). Co-labeling levels with zpr-3 suggested that the majority of rod cells express the NTR-YFP transgene. The NTR-bipolar line uses the Gal4/UAS bipartite system to express two different transgenes, a membrane-tagged YFP and an NTR-mCherry fusion protein that enables cell ablation. In this background, NTR-mCherry expression is sporadic, with the number of NTR+ cells varying from low (~25 cells/retina) to high (hundreds of cells/retina) [45]. To account for this variability, mid-level expressing NTR-bipolar larvae (~100 targeted cells) were visually selected for these studies.

We next verified that a 24 hr 10 mM Mtz prodrug treatment was sufficient to induce loss of NTR-expressing cells and that regeneration occurs upon Mtz washout. Confocal time series imaging was used to follow this process in individual NTR-bipolar and NTR-rod larva (Figs 1a–1b series and S2b and S2d series, respectively). After a 24 hr 10 mM Mtz treatment (from 6–7 days post-fertilization, dpf) followed by 24 hr washout, NTR+ cells in each paradigm were largely absent or appear fragmented (Fig 1a’ and 1b’) in comparison to pre-treatment images (Fig 1a and 1b), indicating strong ablation was achieved. Four days after Mtz was removed (11 dpf), both NTR+ bipolar and rod cells had regenerated (Fig 1a” and 1b”). DMSO controls showed sustained NTR expression in the absence of Mtz (S2a and S2c Fig series). Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) [53] staining confirmed layer-specific cell death in both paradigms (Figs 1c–1f series and S2e and S2f series). Quantification showed a statistically significant increase in DNA damage (TUNEL staining) following Mtz exposures for both transgenic lines (Fig 1g).

Fig 1. Two Nitroreductase (NTR) models enabling inducible retinal cell-type specific ablation.

Fig 1

(a-b series) In vivo time-series imaging following the NTR-bipolar (a-a”) or NTR-rod (b-b”) response to metronidazole (Mtz) treatment to induce cell death and regeneration. Images were taken in the same fish at 6 dpf (before Mtz onset, a, b), 7 dpf (after treatment, a’, b’) and 11 dpf (following recovery, a”, b”). Larvae for each ablation paradigm express CFP derived from Tg(pax6-DF4:gap43-CFP)q01 to label general retinal structures. (c-f series) Representative histological staining for TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) at 7 dpf in uninjured NTR-rod larvae (c-c”) and Mtz treated NTR-rod larvae (d-d”) as well as in uninjured and Mtz-treated NTR-bipolar larvae (e-e”, f-f”, respectively). (g) Quantification of TUNEL+ cell counts at 7 dpf in untreated fish (-Mtz) or following the ablation of each cell type [+Mtz (NTR-rod) and +Mtz (NTR-bipolar)]. For the statistical analysis, Welch’s one-way ANOVA was followed by student’s t test with Dunnett’s method for multiple comparisons correction. (h-k series). Representative histological staining for PCNA (proliferative cell nuclear antigen) at 9 dpf in uninjured NTR-rod larvae (h-h”) and Mtz treated NTR-rod larvae (i-i”) as well as in uninjured (j-j”) and Mtz-treated NTR-bipolar larvae (k-k”). (l,m) Quantification of PCNA+ cell counts at 9 dpf in (l) untreated NTR-rod fish or following the ablation of rods (m) and in untreated NTR-bipolar fish or following the ablation of bipolar cells. For both paradigms, quantification is split into total number of proliferative cells and those in the INL or ONL. For statistical comparisons, Student’s t test was used to assess the indicated paired conditions. Asterisks indicate the following p-value ranges: * = p<0.05, ** = p<0.01, *** = p<0.001, and **** = p<0.0001, “ns” indicates p>0.05.

Characterization of retinal stem cell niches responding to bipolar and rod cell death

As the NTR-rod line consistently labels the majority of rod photoreceptor cells (S1a Fig series), we anticipated rod cell loss would trigger proliferation in both the INL stem cell niche and in ONL precursors, consistent with data from the Hyde lab using a similar transgenic line [54]. Conversely, we expected bipolar cell ablation would result in proliferation predominantly within the INL. INL proliferation is indicative of activation of MG to stem-like state and expansion of a pool of MG-derived progenitor cells (MGPCs). Proliferation of isolated ONL cells is indicative of activation of fate-restricted rod precursor cells. To test which retinal stem cell niches were responsive to cell loss in the two ablation cell paradigms, Mtz-treated and DMSO control retinas were immunolabeled with proliferative cell nuclear antigen (PCNA [39]) at 72h post-onset of Mtz ablation (Figs 1h–1k series and S2g and S2h series). The results showed rod loss led to increased proliferation in both the ONL and INL (Figs 1i’, arrowheads, and 1l and S2h’ arrowheads). In contrast, bipolar loss only led to increased proliferation when combining INL and ONL counts (Figs 1k’, arrowheads, and 1m and S2g’ arrowheads). Both ablation paradigms produced a similar proliferative response in the INL (an average of 2.2 ±2.3, and 3.5 ±3.4 PCNA+ cells for the rod and bipolar paradigms, respectively; student’s t test p-value = 0.25; compare Fig 1l to 1m). Importantly, this suggests that MG/MGPC responses were comparable in rod and bipolar cell ablated larvae. In contrast, and as expected, ONL proliferation was higher in the rod versus bipolar paradigm (an average of 8.3 ±4.0, and 2.6 ±2.7 PCNA+ cells for the rod and bipolar paradigms, respectively; student’s t test p-value < 0.001). Note, proliferation within the INL in NTR-rod lines was typically clustered where the density of cell loss was high (S2h’ Fig), consistent with increased rod cell death activating MG/MGPC proliferation [54]. Note, cells dividing in the ONL following bipolar cell ablation (S2g’ Fig, arrowheads) were presumed to be MGPCs that had migrated to the ONL, consistent with prior studies [3].

Microarray analysis of two cell-specific regeneration paradigms

We next turned to a differential gene expression comparison of our two retinal neuron ablation paradigms. To account for expression changes spanning cell loss and regeneration, eyes were collected from NTR-bipolar and NTR-rod larvae treated ±Mtz across a total of 12 time points, from 0 to 240 hours post ablation (hpa; Fig 2a). As above, cell death was induced by the addition of 10 mM Mtz from 6 to 7 dpf (0 to 24 hpa), followed by wash out and recovery from days 7–16 dpf (24 to 240 hpa; Fig 2a). To assess initial MG stem cell responses to retinal cell loss, early time points were emphasized by collecting samples every 8 hr from 0 to 48 hpa. Eight-hour intervals were used to minimize representation of gene expression changes due solely to circadian cycles. For the later time points, samples were collected at 60, 72, 96, 144, and 240 hpa. Across three biological repeats per time point, a total of 96 eyes were collected per time point for each paradigm (48 DMSO controls and 48 +Mtz samples, S1 Table).

Fig 2. Microarray data collection, DEG identification and top hits.

Fig 2

(a) Experimental design for tissue collection of whole eyes for microarray analysis. Treatment with Mtz for 24h was induced at 6 dpf following screening for NTR-rod+ or NTR-bipolar+ fish. Eyes were collected in triplicate at the following 12 timepoints including t0, t8, t16, 24, t32, t40, t48, t60, t72, t92, t144 and t240. (b) Venn diagram illustrating the total number of differentially expressed genes (DEGs) unique to either cell type or shared between the two at all timepoints. (c) Chart showing distribution of upregulated and downregulated DEGs in each paradigm. (d) Top 10 up and downregulated genes across the entire data set based on p-value as well as the number of timepoints that gene was identified as differentially expressed out of 12.

Genetic differences observed between two cell-specific regeneration paradigms

Using a 1.5-fold change and ≤ 0.05 p-value cutoff compared to expression values at 0 hpa, a total of 2,531 differentially expressed genes (DEGs) were observed across both paradigms. Across all timepoints 918 and 1,249 DEGs were unique to the rod or bipolar cell ablation paradigm, respectively, and 364 DEGs were shared between the two (Fig 2b). DEGs included selective downregulation of known marker genes in the rod (rho) and bipolar paradigms (capb5b) [29], confirming cell-specific loss in each paradigm. Plotting the number of DEGs per each time point showed two peaks at 32 and 60 hpa for the NTR-rod line, and a single peak at 24 hrs post ablation (hpa) for the NTR-bipolar line (Fig 2c). Next, quantitative reverse transcriptase PCR (qRT-PCR) was used to validate gene expression changes for 8 genes per each paradigm at 0, 24, 48, 72 and 96 hpa (S3 Fig, primers used are listed in S2 Table). Genes in the Janus kinase-signal transducer and activator of transcription (JAK/STAT) and Wnt pathways were selected for qRT-PCR analysis as both have been implicated in regeneration of the targeted cell types [10,55]. Temporally-resolved expression trends, rather than absolute fold change, were utilized for validation as differences in normalization methods have the potential to impact overall expression levels [56]. These data revealed only minor differences in expression patterns between the microarray and qRT-PCR suggesting the microarray data accurately reflect gene expression changes (S3 Fig). The top 10 up and down DEGs at all timepoints for each paradigm were then identified by lowest single p-value, many passing the DEG threshold at multiple timepoints during out study (Fig 2d).

Transcriptomic differences following regeneration of Uniquely targeted neurons

To identify differentially regulated signaling pathways at each time point, and across broader temporally-resolved expression patterns, several analysis methods were used. First, volcano plots and pathfindR [57] analyses were performed to reveal paradigm-specific and shared DEG-associated signaling pathways at each time point (S4S14 Figs). Volcano plots correlate log-fold changes in gene expression to p-values, with upregulated and downregulated DEGs indicated by orange and blue dots, respectively (S4aS14a Figs). Venn diagrams show the total number of DEGs unique to each paradigm and the number of shared DEGs (S4bS14b Figs). Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis via the pathfindR package revealed the top enriched pathways associated with either the rod or bipolar paradigm-specific DEGs, as well as shared DEGs (S4cS14c Figs).

In order to examine DEGs contributing to different stages of the regeneration process, we identified DEGs whose expression profile fit one of four gaussian-type patterns during the regenerative process: increased (up early) or decreased (down early) from16 to 32 hpa, and increased (up late) or decreased (down late) from 48 to 72 hpa (Fig 3a). Notably, this captured the majority of DEGs observed. Heatmaps are shown for the top 25 DEGs for each pattern in both the NTR-rod and NTR-bipolar paradigms (Fig 3b and 3c). The two reciprocally regulated DEG patterns–up/down early (Fig 4) and up/down late (Fig 5)–were evaluated using KEGG, Gene Ontology (GO) and Ingenuity Pathway Analysis (IPA). For early pattern DEGS (Fig 4a), the top 10 pathfindR KEGG terms were plotted for rod-specific, bipolar-specific and shared gene sets (Fig 4b–4d). Predictably for the rod paradigm, phototransduction was the most enriched term. Additional rod-specific KEGG pathways included RNA degradation, proteosome, and necroptosis (Fig 4b). For the bipolar paradigm, p53 signaling was the most enriched term, other pathways included autophagy, nucleoside excision repair, and cysteine and methionine metabolism (Fig 4c). Shared KEGG pathway terms for early pattern DEGs included phototransduction, mTor signaling, and glutathione metabolism (Fig 4d). Gene Ontology (GO) analysis of the same datasets revealed additional terms, such as circadian rhythm and ncRNA processing for the rod paradigm, cellular apoptotic processes and response to stress for the bipolar paradigm, and response to temperature stimulus and DNA conformation change among shared terms (Fig 4e–4g). Lastly, IPA was used to generate unsupervised networks from the early DEG lists for the NTR-rod and NTR-bipolar paradigms (Fig 4h and 4i). For the rod paradigm, signal transducer and activator of transcription 3 (STAT3) was identified as the central mediator of the early DEG network along with multiple cytokine terms (e.g, interleukin-1b and 6, IL-1B, IL-6) and associated terms for the oxidative stress response (Fig 4h). In the bipolar paradigm, the central mediator was peroxisome proliferator-activated receptor gamma (PPARG), other noteworthy genes included tumor protein 53 (tp53), the cytokine il10, stat5a and stat5b (Fig 4i). We then produced a summary bar chart of all related immune terms identified from IPA. Early pattern IPA-implicated pathways of the rod paradigm included JAK family kinases, chemokine (C-X-C motif) receptor 4 (CXCR4), IL-6, interferon, and iNOS signaling, as well as multiple other IL-family cytokines (S15 Fig). For the bipolar paradigm, early pattern IPA terms included similar IL-family cytokines but also added prolactin and leukocyte extravasation signaling, as well as phagosome maturation (S16 Fig). Combined, KEGG, GO, and IPA analysis revealed that factors implicated in regulating the early stages of regeneration are linked more to the loss of individual retinal cell types than to a common signature across cell types.

Fig 3. Identification of early and late DEG patterns and heatmaps for top DEGs in each.

Fig 3

(a) DEGs for each paradigm were split into upregulated (red) and downregulated (blue) as well as early (16-32h) and late (48-72h) based on peaks in Fig 2. The distribution of DEGs in these 8 patterns is shown in terms of unique and shared DEGs across both cell types. (b-h) The top 25 genes are plotted in heatmaps as a function of the largest fold changes at the middle timepoint in each pattern (24h and 60h) to demonstrate top genes defining each 8 patterns (NTR-rod and NTR-bipolar for patterns early-up, early-down, late-up and late-down).

Fig 4. Pathway analysis of early DEG pattern in both paradigms.

Fig 4

(a) Curve demonstrating expression pattern for early upregulated (red) and downregulated (blue) genes along our timepoints. (b-d) Top 10 enriched KEGG pathway terms including p-value and # of genes found as DEGs in the NTR-rod (b), NTR-bipolar (c) or from shared DEGs across both paradigms (d). (e-g) Top 10 enriched Gene Ontology pathway terms including fold enrichment and false discovery rate in the NTR-rod (e), NTR-bipolar (f) or from shared DEGs across both paradigms (g). (h-i) Unsupervised gene networks produced from ingenuity pathway analysis for DEGs in the NTR-rod (h) and NTR-bipolar (i) paradigm. Orange indicates upregulated gene/pathway term while blue indicates downregulated.

Fig 5. Pathway analysis of late DEG pattern in both paradigms.

Fig 5

(a) Graphic demonstrating expression pattern for late upregulated (red) and downregulated (blue) genes along our timepoints. (b-d) Top 10 enriched KEGG pathway terms including p-value and # of genes found as DEGs in the NTR-rod (b), NTR-bipolar (c) or from shared DEGs across both paradigms (d). (e-g) Top 10 enriched Gene Ontology pathway terms including fold enrichment and false discovery rate in the NTR-rod (e), NTR-bipolar (f) or from shared DEGs across both paradigms (g, only 7 terms enriched in this group). (h-i) Unsupervised gene networks produced from ingenuity pathway analysis for DEGs in the NTR-rod (h) and NTR-bipolar (i) paradigm. Orange indicates upregulated gene/pathway term while blue indicates downregulated.

The same analysis methods were used to evaluate late pattern DEGs (Fig 5a). A subset of top KEGG terms stayed consistent with early pattern DEGs including phototransduction and RNA degradation for the rod paradigm, autophagy and p53 for the bipolar paradigm, and also autophagy for shared genes (Fig 5b–5d). The top enriched KEGG terms were DNA replication and cell cycle for the rod and bipolar paradigms, respectively. Newly identified terms included mismatch repair for rods, Toll-like receptor signaling for bipolars, and cellular senescence for the shared set (Fig 5b–5d). Enriched GO terms similarly included some overlap with early pattern terms (Fig 5e–5g), new rod GO terms included ribosome biogenesis, nuclear RNA surveillance, and sno(s) RNA processing (Fig 5e). New bipolar terms included oxoacid metabolic process, circadian rhythm, and response to peptide hormone (Fig 5f). Fewer shared DEGs in the late pattern data lead to fewer enriched GO terms, however, the majority were new including cellular response to DNA damage and regeneration (Fig 5g). IPA analysis of late pattern rod data similarly identified many of the same immune-related pathways implicated in early pattern rod data, including IL-family cytokines. New terms included prolactin, CNTF, and GM-CSF signaling (S17 Fig). The late pattern rod network had fewer nodes than the early network and was centered on IL-6 (Fig 5h). Late pattern bipolar IPA terms also shared many immune-related terms with early pattern data. Additional terms included CD40, granzyme B, and TNFR signaling (S18 Fig). The late pattern bipolar network was centered on interferon regulatory factor 7 (IRF7, Fig 5i). Finally, a deep literature search was conducted on the top ~50–60 DEGs in each coordinated pattern for each paradigm. More specifically, given the importance of the immune system in regulating regeneration in our NTR-rod model [39,58], we asked whether these genes had previously been linked to immune responses or regeneration in general (S19a Fig). In total, we found that ~38% and ~44% of the top DEGs in the rod and bipolar paradigms, respectively, had been linked to immune system function. In addition, ~27% of the DEGs from both paradigms had been linked to regeneration in prior studies (S19b Fig).

Validation of role for stat3 in induced rod photoreceptor regeneration

The expression of stat3 increased following retinal cell loss in both the NTR-rod and NTR-bipolar paradigms. However, the increase in stat3 was far more prominent in the NTR-rod fish paradigm regarding both fold change (S3a Fig) and the number of timepoints this was observed (8 of 12 for NTR-rod, 4 of 12 for NTR-bipolar). For functional tests in NTR-rod fish, CRISPR/Cas9 redundant targeting was used to mutate stat3 in G0 larvae, i.e., to create crispants [59] (Fig 6a). Reduced expression was confirmed via qPCR in a subset of injected and non-injected control fish (Fig 6b). At 5 dpf, rod photoreceptors were ablated (10 mM 24h Mtz). Subsequently, an established Tecan fluorescent plate reader-based assay as well as in vivo imaging was used to assess: rod cell death at 7 dpf (Fig 6c) and rod cell regeneration at 9 dpf (Fig 6d–6f). Mutation of stat3 led to significantly impaired rod regeneration (-23%) compared to wildtype fish, thereby validating the requirement for stat3 in rod cell regeneration. Lastly, to examine the mechanism by which stat3 disruption leads to reduced regeneration, stem-cell proliferation was assessed following ablation in wildtype and mutant fish. Akin to our initial classification of Mtz-induced proliferation (Fig 1l), death of rods led to proliferation in both the INL and ONL. PCNA immunostaining in stat3 crispants showed a significant decrease in total proliferation compared to wildtype fish (Fig 6g–6i). This suggests stat3 loss impairs progenitor cell proliferation at this timepoint, leading to fewer regenerated rod cells.

Fig 6. Stat3 is required for rod photoreceptor regeneration.

Fig 6

(a) Experimental design depicting CRISPR/Cas9-based mutation (MUT) of stat3 in NTR-rod embryos. Control (+Mtz) and crispant NTR-rod larvae (+Mtz, stat3 MUT) were treated with 10mM Mtz from 5–6 dpf and rod fluorescence was assessed via plate reader assay at 7 dpf (to examine the extend of rod cell loss) and 9 dpf (to examine the extent of rod cell regeneration). Created with Biorender.com. (b) Relative stat3 mRNA expression (qRT-PCR assay) in non-injected controls compared to stat3 crispant fish. (c) Quantification of NTR-YFP expression in rod cells by plate reader assay at 7 dpf in non-ablated (-Mtz) wildtype, and ablated control (+Mtz) and stat3 MUT larvae (+Mtz, stat3 MUT). (d-e) Representative in vivo confocal images of regenerated rod cells at 9 dpf in control (+Mtz) and stat3 MUT larvae (+Mtz, stat3 MUT). (f) Quantification of rod cell regeneration by plate reader assay at 9 dpf in control (+Mtz) and stat3 MUT larvae (+Mtz, stat3 MUT). (g-h) Representative immunohistological staining for PCNA at 7 dpf in control (+Mtz) and stat3 MUT larvae (+Mtz, stat3 MUT) fish. (i) Quantification of INL, ONL, and total PCNA+ cells at 7 dpf in control (+Mtz) and stat3 MUT larvae (+Mtz, stat3 MUT). For statistical comparisons, Student’s t test was used to assess the indicated paired conditions. Asterisks indicate the following p-value ranges: * = p<0.05, ** = p<0.01, *** = p<0.001, and **** = p<0.0001, “ns” indicates p>0.05.

Enhanced rod photoreceptor regeneration in txn, stat5a/b and c7b crispants

Finally, to identify genes whose disruption could lead to enhanced rod cell regeneration, we tested a panel of 6 additional genes using the crispant strategy. Targets were selected from: immune-related genes upregulated at multiple timepoints following rod ablation (c7b, txn), genes upregulated during bipolar but not rod regeneration (pparg, stat5a/b), genes upregulated in MG during photoreceptor regeneration in adult zebrafish (prdm1a [12]), or genes implicated in maintaining MG quiescence in mice following a NMDA-induced retinal injury (nfia [29]). Sibling NTR-rod larvae were injected with 4xsgRNAs for each gene of interest and rod cells ablated at 5 dpf (10 mM 24h Mtz). Regeneration was then assessed by plate reader at 9 dpf (Fig 7a). Of the six factors tested (Fig 7b and 7c), mutation of three led to enhanced rod regeneration (from least to greatest effect: txn (+70%), stat5a/b +85%), and c7b (+96%), while three had no statistically significant effect (nfia, pparg, prdm1a). Analysis of effects on rod cell development at 5 dpf showed a mild increase following txn mutation (+29%), while there was no effect for stat5a/b or c7b mutations. Lastly, mutation of txn, stat5a/b, and c7b had no effects on the efficacy of Mtz-induced rod cell ablation with YFP levels dropping to non-mutagenized ablated control levels at 7 dpf in all cases (S20 Fig).

Fig 7. Rod cell regeneration is enhanced in txn, stat5a/b and c7b crispants.

Fig 7

(a) Experimental design depicting CRISPR/Cas9-based targeting of target genes via CRISPR/Cas9 in NTR-rod embryos. Control (+Mtz) and mutated NTR-rod larvae (+Mtz, gene target MUT) were treated with 10mM Mtz from 5–6 dpf and rod fluorescence was assessed via plate reader assay at 9 dpf (to examine the extent of rod cell regeneration). Created with Biorender.com. (b) Quantification of rod cell regeneration by plate reader assay at 9 dpf in Mtz-treated control and MUT larvae for target genes pparg, prdm1a, nfia, txn, stat5a/b and c7b. (c) Representative in vivo confocal images of regenerated rod cells at 9 dpf in control (+Mtz) and stat5a/b or c7b MUT larvae. For statistical comparisons, Welch’s one-way ANOVA was followed by student’s t test with Dunnett’s method for multiple comparisons correction. Asterisks indicate the following p-value ranges: * = p<0.05, ** = p<0.01, *** = p<0.001, and **** = p<0.0001, “ns” indicates p>0.05.

Discussion

Promotion of retinal regeneration would provide a transformative therapeutic approach for patients with blinding degenerative diseases. One strategy to achieve this goal is to induce endogenous human MG to respond to cell loss and regenerate lost retinal neurons, a process that occurs naturally in zebrafish. Zebrafish studies have identified several genes that regulate retinal regeneration (ascl1a [60], lin-28 homolog A [8,11], sry-box transcription factor 2 [61], stat3 [62]) as well as gene networks coordinating MG states (rest, reactivity, proliferation) following retinal damage [29]. Each of these studies induced widespread retinal damage where the regenerative process largely mirrors retinal development [3,12]. Conversely, retinal degenerative diseases typically involve the slow progressive loss or dysfunction of specific cell types, such as rod photoreceptors in retinitis pigmentosa [31] and retinal ganglion cells in glaucoma [30,31]. Interestingly, several zebrafish mutants fail to regenerate retinal neurons when loss is slow, progressive, and cell-type specific, i.e., akin to disease conditions [47]. This suggests that a threshold of cell death is required to trigger retinal regeneration and that models enabling control over the onset, extent, specificity and duration of cell death can expand our understanding of how regeneration is controlled under disease-mimicking conditions. For instance, Hyde and colleagues have shown that the extent of rod cell loss determines MG responsiveness: low rod cell loss inducing proliferation solely in “rod-committed” ONL precursors while extensive rod loss elicited responses in both ONL precursors and MG/MGPCs in the INL [54]. Moreover, cell-specific retinal cell ablation models have revealed that regenerative processes can exhibit “fate-bias”, where newly generated cell fates favor the cell type that was lost [1316]. Subtler fate biases follow even widespread retinal damage [63], suggesting that the regenerative process is informed by the nature of the injury/cell loss paradigm to guide retinal progenitor cell fate decisions. The sequence of temporally-delineated cell fates attending development appear to be recapitulated following widespread retinal injury [12]. However, how biases in fate decisions are controlled following either widespread or selective retinal cell loss, is unknown.

In mice, overexpression of neurogenic factors such as ascl1 [4,5,7] in MG, and knockout of inhibitory factors such as the nfi genes [29] have been shown to promote limited regenerative responses. However, the neuronal cell types generated with these methods have been predominantly limited to bipolar-like cells [5], neither well matched to the cell types lost nor particularly relevant to retinal disease. However, inroads into producing more disease-relevant cell types such as retinal ganglion cells have recently been made by adding additional neurogenic factors such as pou4f2 and isl1 [7,64,65]. Increased understanding of mechanisms regulating fate-biased regeneration may help to promote the full regenerative potential of the mammalian retina. Here, we investigated transcriptomic responses to the selective loss of two “late born” retinal cell types [12], rod photoreceptors and bipolar interneurons, in an effort to reveal mechanisms that inform and regulate fate-biased regenerative mechanisms in the zebrafish retina.

We first characterized NTR-rod and NTR-bipolar transgenic lines following Mtz-induced cell loss, confirming the specificity of cell loss and quantifying proliferative responses in the INL and ONL (Fig 1). Our data showed proliferative responses in both the INL and ONL following rod ablation (Fig 1l), consistent with extensive rod cell loss activating MG, while bipolar ablation led primarily to INL proliferation (Fig 1m). Importantly, both paradigms induced INL proliferation at equivalent levels, suggesting comparable MG responses. Accordingly, the differences in gene expression observed between these paradigms cannot be explained solely by activation of ONL rod-committed precursors in the NTR-rod paradigm. We do, however, acknowledge that the differential involvement of rod precursors must account for some of the differences in gene expression we observe between paradigms. Additional variables that could lead to observed differences include: (1) relative expression levels, intracellular localization, and/or transgene copy number of NTR, the total number of cells lost, the genetic background of each line, and differential timing of cell loss and/or regeneration kinetics relative to sample collection timepoints. A particularly intriguing possibility is that different subpopulations of MG may exist that are dedicated to the regeneration of specific retinal cell types. Jusuf and colleagues recently presented data consistent with this concept using single cell transcriptomics to suggest as many as six different MG subtypes exist in the zebrafish retina [66].

To comprehensively characterize transcriptomic changes during rod and bipolar cell regeneration, samples were collected across 12 time points encompassing cell loss and regeneration (Fig 2a). Prior microarray studies have successfully identified genes associated with MG activation [67] and networks activated following various retinal injury paradigms [62,6872]. More recently, single-cell RNAseq (scRNA-seq) and ATAC-seq (Assay for Transposase-Accessible Chromatin) were used to compare light and NMDA induced retinal cell ablation paradigms during early phases of the regenerative process [29]. Here, by expanding the number of time points analyzed we sought to identify genes/pathways associated with: 1) inflammation and immune cell activation, 2) stem cell activation, 3) MG/MGPC proliferation, and 4) MGPC differentiation. We emphasized early time points (every 8 hr from 0–48 h) to identify genes linked to the initiation of fate-biased regenerative processes. A total of 364 shared, 918 rod-specific, and 1249 bipolar-specific DEGs were identified (Fig 2b). Overall, shared DEGs/pathways were limited more to early time points, while paradigm-specific DEGs/pathways were identified throughout the study. It is possible that there are more unaccounted for shared and unique DEGs that could arise from potential differences in the genetic makeup of the models. The number of DEGs diminished for both cell-types starting at 72 hpa. That paradigm-specific DEGs predominated supports the concept that injury/cell loss specifics inform the regenerative process [3,1116].

KEGG pathway analysis per each timepoint identified previously implicated pathways (e.g., mTor, Notch, and Wnt signaling) [8,55,69,73,74], and terms linked to the regulation of stem cell function but not previously associated with retinal regeneration (e.g., glutathione metabolism [75], FoxO signaling [76], and cellular senescence [77]). To enhance pathway analyses, we grouped DEGs into four coordinately regulated sets for each paradigm: up or down early (16–32 hr) and up or down late (48–72 hr, Fig 3a and 3b). This accounted for the majority of DEGs and reinforced that paradigm-specific DEGs outnumbered shared DEGs (Fig 3c). Representative genes in the NTR-rod early up group included known factors (e.g., activating transcription factor 3- atf3, stat3) [62,78] and genes not previously associated with retinal regeneration (e.g., glutathione S-transferase pi 1- gstp1). Among the known set, factors associated with immune system reactivity were prevalent, including a number of genes previously shown to be upregulated in MG at 16h post light ablation in adult zebrafish [62] (e.g., janus kinase 1- jak1, stat3, suppression of cytokine signaling 3b- socs3b, cytokine inducible SH2-containing protein- cish, irf9 and complement component 7b- c7b). GO analysis additionally identified shared late pattern enrichment for the broad term “regeneration” based on the differential regulation of the genes annexin A1a- anxa1a, ubiquitin-like with PHD and ring finger domains 1- uhrf1, socs3a, capthespin Ba- ctsba, legumain- lgmn, major vault protein- mvp, v-fos FBJ murine osteosarcoma viral oncogene homolog Ab- fosab, and GLIS family zinc finger 3- glis3 (Fig 5). Next, IPA was used to reveal differential regulation of pathways at early and late stages of regeneration in each model. For both cell types, and at both early and late timepoints, multiple shared and unique immune-related pathways were identified, e.g., cytokines, JAK/STAT, Toll-like receptor and prolactin signaling (S15 Fig). We then produced unsupervised DEG networks using the coordinated expression pattern data, i.e., rod-early, rod-late, bipolar-early and bipolar-late. Known pro-regenerative and pro-inflammatory factors STAT3 and IL-6 [62,79] were identified as central mediators in the rod paradigm (Figs 4h and 5h), while PPARG and IRF7 were implicated as central mediators for the bipolar paradigm (Figs 4i and 5i). PPARG has recently been tied to zebrafish retinal progenitor cell function in adults through interactions with metabolic pathways [80]. Interestingly, IRF7 has been implicated as a key regulator of microglia reactivity, its upregulation promoting a phenotypic switch from an inflammatory to anti-inflammatory state, aka stimulating resolution of microglia activation [81,82]. Our prior work suggested that accelerating the resolution process by exposure to the immunosuppressant dexamethasone 24 hrs after induction of rod cell ablation led to enhanced rod cell regeneration in zebrafish [83]. Together, these studies implicate induction of IRF7 expression as potential strategy for promoting neuronal regeneration.

Both IL-6 and interferons activate JAK/STAT signaling [79,84], a known mediator of the response to retinal damage [62] regulating cell migration [85], proliferation [62], apoptosis [86], immune system [87] and oxidative stress [88] responses. DEGs in the JAK/STAT family were primarily upregulated in the rod (e.g, stat3, jak1, cish, socs1a/3a/3b) and bipolar paradigms (e.g, cish, socs1a/3a/3b, stat1a/1b/2/5a/5b). However, the specific JAK/STAT family members involved differed between our two paradigms (e.g., stat3 for rod and stat1a/b, stat2 and stat5a/b for bipolar). Similarly, different cell death pathways were also implicated, NTR-rod being linked to necroptosis (Fig 4b) while NTR-bipolar was linked to apoptosis (Fig 4c and 4f), These findings align with a recent drug screen in the same NTR-rod model where inhibitors and genetic disruption of parthanatos and necroptosis pathways protected rods from cell death while inhibition of apoptosis did not [41]. Interestingly, recent work in multiple mouse tumor models links necroptotic signaling to the activation of IL-6 and STAT3 [8991] while apoptotic signaling was linked to STAT5 activation [92], matching gene expression and cell death patterns in our models. JAK/STAT signaling receives feedback inhibition from Suppression of Cytokine Signaling (SOCS) genes [93]. Notably, ablation of both cell types was followed by upregulation of socs3a, socs3b, socs1a and cish. Socs3a has been implicated as a mediator of hair and liver cell regeneration in zebrafish through activation of resident stem cells and progenitor differentiation [94,95], and is strongly upregulated in an adult zebrafish photoreceptor lesion model [70].

CRISPR/Cas9 mediated disruption of stat3 led to significant reductions in proliferation and rod photoreceptor regeneration kinetics (Fig 6), consistent with a reduction in photoreceptor regeneration following light-damage in stat3 morpholino injected eyes [62]. In contrast, disruption of txn (thioredoxin), stat5a/b and c7b (complement factor 7b) led to enhanced rod regeneration. C7b, txn and stat5a/b are each key immune system factors, and chromatin data from the ENCODE project identified c7b and txn as target genes of the Stat5 transcription factor in humans [96]. Mutation of these factors can now be added to a growing list of immunomodulatory techniques that enhance rod photoreceptor regeneration in the larval zebrafish retina [39,58,97]. When combined with our observations of robust differences in immune system activation during regeneration of rods or bipolar cells, we interpret this to indicate that the immune system is a key regulator of fate-biased regeneration. Further insights into the regulation of fate-biased regenerative mechanisms will likely aid in the development of cell-type targeted therapeutic strategies to restore vision.

Materials and methods

Ethics statement

All procedures were completed in compliance with animal care and use protocols approved by both the Medical College of Georgia (now Augusta University) Institutional Animal Care and Use Committee (IACUC), as well as the Johns Hopkins University Animal Care and Use Committee (ACUC).

Aquaculture

Zebrafish were maintained under standard environmental conditions (~28°C, 14hr:10hr light:dark cycle). Larvae were fed paramecia starting at 5 days post-fertilization (dpf), then paramecia and Artemia salina from 9–16 dpf. Late stage larvae (e.g., 8 dpf) slated for imaging were given 1-phenyl 2-thiourea (PTU) beginning at 1 dpf and kept in 12 well plates in 5 ml of system water until 12 dpf after which they were sacrificed.

Transgenic lines

A bipartite Gal4/UAS [98] transgenic zebrafish line derived with a 1,482 bp promoter element from the nyctalopin (nyx) gene [99,100], Tg(nyx:Gal4-VP16)q16a, and a Gal4-driven reporter, (UAS:GAP-YFP)q16b, expresses membrane-tagged yellow fluorescent protein (YFP) in a subpopulation of bipolar cells [48]. Crosses to a UAS-reporter/effector line facilitating prodrug-induced cell ablation, Tg(UAS-E1b:NfsB-mCherry)c264 [101], resulted in triple transgenic fish expressing an NTR-mCherry fusion protein in subsets of nyx-promoter targeted bipolar cells (q16a;q16b;c264; hereafter, NTR-bipolar lines). A transgenic line derived with a 3.7 kb promoter element from the rhodopsin (rho) gene (kind gift of Dr. Shoji Kawamura) [49] expresses a YFP-NTR fusion protein in rod photoreceptor cells, Tg(rho:YFP-Eco.NfsB)gmc500 [46] (hereafter, NTR-rod lines). Retinal morphology was monitored during imaging studies by crossing both NTR lines with Tg(pax6-DF4:gap43-CFP)q01 which expresses membrane tagged CFP throughout the retina (see Fig 1A and 1B) [102]. Transgenic fish were propagated in the roy orbison (aka, mpv17a9/a9, hereafter roya9/a9) [103,104] pigmentation mutant background to facilitate intravital imaging [105]. To minimize potential effects of genetic background regular outcrosses to an AB wildtype strain (WT) and roy lines from other sources were performed to increase genetic diversity.

Mtz treatment

For histological experiments, in vivo imaging experiments and all microarray tissue collections, transgenic NTR-bipolar and NTR-rod larvae were screened and separated into two equal sized groups at 6 dpf: 1) non-treated controls (Cntl); and 2) those treated with 10mM Mtz for 24 hr to induce cell death, from 6–7 dpf (or DMSO-treated controls where applicable). After Mtz treatment, fish were rinsed into system water and fed paramecia until sacrificed.

mRNA isolation and preparation

Whole eye mRNA was prepared across twelve time points: t0 (just prior to Mtz exposure); t8, t16, and t24 hr (during Mtz treatment); and t32, t40, t48, t60, t72, t96, t144, and t240 hr (after Mtz removal during recovery (Fig 2A). Sample collection started at 8:00 a.m. on the day larvae reached 6 dpf. At each time point, 16 eyes from 8 larvae were isolated per condition. To isolate eyes, larvae were euthanized in 0.4% tricaine for 5 mins followed by cervical transection. Whole eye pairs were manually isolated under an Olympus SZX16 epifluorescence stereoscope and immediately placed into a chilled/sterile 1.5 ml tube with 50 μl of TriZOL (Life Technologies); samples were then stored at -80°C until extraction. This protocol was followed for three biological repeats per condition/time point for NTR-rod and NTR-bipolar lines. Samples were batch extracted and processed following the final time. All samples were processed in the Medical College of Georgia (MCG, former Mumm lab location) Integrated Genomics Core for mRNA isolation, cDNA library construction, and microarray hybridization.

Microarrays

GeneChip Zebrafish Genome Microarrays (Affymetrix) were processed by the MCG Genomic Core. Each run involved sibling zebrafish and consisted of 23 RNA samples across each regenerative paradigm—1 pretreatment, and 11 time points from the control and Mtz treatment groups. RNA sample quality was assessed by concentration and the RNA Integrity Number (RIN), an algorithm that assigns integrity values to RNA measurements [106]. Only samples attaining a minimal concentration of ≥100ng/μL (5μL total) and a RNA integrity number (RIN) value of ≥8 were used for microarray hybridizations [106]. Runs where a minimum of 21 of 23 samples were deemed of good quality were utilized in the microarray studies. Three runs were processed per regenerative paradigm resulting in six microarray sets (S1 Table) and a total 138 microarrays overall.

Tissue preparation and immunohistochemistry

For immunohistochemistry, larval zebrafish were euthanized, fixed in 4% paraformaldehyde (PFA) for 8 hr, washed three times in 1x PBS (phosphate buffered saline; EMD Millipore) for 30 min and stored at 4°C. Samples were mounted in cryogel embedding medium within the next 2–4 days, frozen in liquid nitrogen then stored at -80°C until sectioned in the lateral plane at 25 μm thickness with a cryostat. Sliced sections were collected on standard microscope slides and stored at 4°C.

For immunolabeling, slides were air dried at room temperature for ~1 hr, rinsed in 1xPBS and then re-fixed with 4% PFA for 15 min. PBST rinses (1xPBS +0.1% Tween20, Fisher Scientific) were conducted to remove trace PFA followed by 5 min antigen retrieval with SDS (1% Sodium Dodecyl Sulfate; Fisher Scientific) in PBS. The blocking phase was performed with 3% goat serum in PBDT (1xPBS, 1% BSA, 1% DMSO, 0.1% TritonX-100) for 30 min and incubated with primary antibody/1% goat serum/PBDT overnight at 4°C. The next morning, slides were rinsed in PBST, stained with secondary antibody/PBDT ~1 hr in a light protected humidity chamber and cover-slipped (22x50 mm, Fisher Scientific). PBST rinses removed unbound secondary antibody. Samples were protected with Vectashield + DAPI (Vector Laboratories) and cover-slipped (24x50 mm, Fisher Scientific).

Primary antibodies included: mouse anti-PCNA monoclonal antibody (1:1000, clone PC10; Sigma Aldrich), rabbit anti-Caspase-3 monoclonal antibody (1:500, clone C92-605; BD Biosciences), Click-iT Tunel Alexa Fluor 647 (1:500; Life Technologies), mouse anti-zpr-1 monoclonal antibody (1:750; ZIRC), mouse anti-zpr-3 monoclonal antibody (1:750; ZIRC), mouse anti-ZS-4 monoclonal antibody (1:750; ZIRC). Secondary antibodies included: anti-mouse Alexa Fluor 430 (1:500; Life Technologies), anti-mouse Alexa Fluor 635 (1:500; Life Technologies), anti-rabbit Alexa Fluor 430 (1:500; Life Technologies).

Cell counting and analysis

Images were collected with an Olympus FV1000 Confocal Microscope (405, 440, 488, 515, 559, and 635nm laser lines). Stacked confocal images were obtained using a 40x oil immersion objective with a 2.5 μm step size, 130 μm aperture, and 10 μm total depth. Five sections were collected per retina centered around the optic nerve. Images (Olympus.OIB format) were analyzed using ImageJ. Manual cell counts were averaged across sections per retina and averaged within each group. For statistical comparisons, Student’s t test was used to assess paired conditions while Welch’s one-way ANOVA followed by Dunnett’s test for multiple comparisons was used to assess differences across more than two conditions. Results from all statistical comparisons are shown graphically.

Sample quality and differential expression analysis

Data were collected from 138 Genechip Zebrafish Genome arrays (Affymetrix) across four conditions: NTR-rod cntrl, NTR-rod Mtz, NTR-bipolar cntrl, and NTR-bipolar Mtz. The Bioconductor suite in the R statistical software [107], LIMMA [108], Carmaweb [109], and Microsoft Access were used for data processing, differential expression testing and storage. Prior to statistical analysis, Robust Multi-array Average (RMA) pre-processing routine [110] and Quality control assessments [111] were used for background correction, normalization and quality control. A set of differentially expressed genes was derived using LIMMA with a false discovery rate adjusted p-value of 0.05. Differentially expressed genes were defined as those expressing a 1.5-fold up or downregulation at any time point in regeneration. Pathway analysis was performed using QIAGEN Ingenuity Pathway Analysis (IPA), Gene Ontology (GO) and KEGG pathway analysis (via the pathfindR R studio package). IPA was also utilized to generate gene networks. An adjusted p value below 0.05 was used throughout as a cutoff for significance in all analyses.

qPCR processing

Extracted mRNA samples were reverse transcribed (Qiagen Omniscript RT kit, Qiagen) and stored at -20°C. Samples were run in triplicate using the BioRad iQ SYBR Green Supermix (BioRad) in iCycler IQ 96 well PCR plates (Bio-Rad) on a BioRad iCycler equipped with an iCycler iQ Detection System. The protocol consisted of three phases: 1) 92°C for 10:00 min, 2) 50x 92°C for 00:15 min, 60°C for 01:00 min, 3) 81x 55°c➔95°c for 00:10 min. β-actin served as the house keeping gene and 2−ΔΔCT method was used for normalization to ensure equal amounts of cDNA for comparisons. qPCR primers were designed using the online tool QuantPrime.

CRISPR/Cas9 mediated targeting

CRISPR/Cas9 mediated redundant targeting injections were performed at the one-cell stage of gmc500 embryos utilizing the published strategy and gRNA table by Wu et al [59]. Published sgRNAs for stat3, c7b, txn, prdm1a, pparg, stat5a/b, and nfia were ordered as DNA oligos, assembled with the general CRISPR tracr oligo, and then transcribed using pooled in vitro transcription (HiScribe T7 High Yield RNA Synthesis kit, New England BioLabs) and cleaned up with the NEB Monarch RNA Cleanup kit. A mixture of all four sgRNAs (1 ng in total) and Cas9 protein (2.5 μM, IDT) was injected into rho:YFP-NTR embryos at the one-cell stage for targeting each gene.

Quantitative real-time polymerase Chain reaction (qRT-PCR)

To validate stat3 mutation by CRISPR/Cas9 redundant targeting, 3 groups of 10 larvae of both uninjected and 4xgRNA injected transgenic larvae at 2 dpf were processed through a previously published protocol to measure gene expression with qRT-PCR [41]. Briefly, RNA was purified using NEB Monarch RNA Cleanup kit and reverse transcribed to cDNA using qScript cDNA synthesis kit (QuantaBio). Quantitative PCR was conducted using designed primers with the primerdb database and PowerUp SYBR Green Master Mix (ABI) in QuantaStudio (ABI). ΔΔCT analysis was performed to calculate relative fold change in gene expression levels between Cas9/4xgRNA injected larvae and controls. Each experiment was performed in triplicate.

ARQiv scans to measure rod photoreceptor development, loss, and regeneration

Wildtype non-injected and target sgRNA injected Tg(rho:YFP Eco. NfsB)gmc500 larvae were treated with Mtz at 5 dpf and subsequently rod cell loss or regeneration was measured at 7 dpf and 9 dpf, respectively, using the ARQiv system, as previously described [39]. Effects on rod cell development were measured at 5 dpf in mutant groups that showed significantly enhanced rod regeneration.

Supporting information

S1 Fig. Confirmation of NTR-rod transgene specificity.

(a-a”) Histological staining in the NTR-rod model showing transgenic Rho:YFP-NTR expression (green) along with antibody staining for rod outer segment marker Zpr-3 (purple). (b-b”) Histological staining in the NTR-rod model showing transgenic Rho:YFP-NTR expression (green) along with antibody staining for cone marker Zpr-1 (purple).

(TIF)

S2 Fig. Additional in vivo imaging and TUNEL/PCNA histological imaging.

(a-b series) In vivo time-series imaging following NTR-rod larvae that were uninjured (a-a”) or received Mtz (b-b”). Images were taken in the same fish at 6 dpf (before Mtz onset in +Mtz larvae), 7 dpf (after Mtz removal) and 11 dpf (following recovery). (c-d series) In vivo time-series imaging following NTR-bipolar larvae that were uninjured (c-c”) or received Mtz (d-d”). Images were taken in the same fish at 6 dpf (before Mtz onset in +Mtz larvae), 7 dpf (after Mtz removal) and 11 dpf (following recovery). Larvae for each ablation paradigm express CFP derived from Tg(pax6-DF4:gap43-CFP)q01 to label general retinal structures (a-d series). (e-f series) Histological staining in uninjured and +Mtz eyes at 7 dpf for TUNEL in the NTR-bipolar (e-e’) and NTR-rod (f-f’) paradigms. (g-h series) Histological staining in uninjured and +Mtz eyes at 9 dpf for PCNA in the NTR-bipolar (g-g’) and NTR-rod (h-h’) paradigms.

(TIF)

S3 Fig. qRT-PCR validation of mRNA expression changes.

(a, b) A subset of tested genes were selected for validation using quantitative Reverse Transcription–Polymerase Chain Reaction (qRT-PCR). 8 genes were selected for a temporal analysis from 0-72h post Mtz in either the NTR-rod (A) or NTR-bipolar (B) paradigm with beta actin serving as a control.

(TIF)

S4 Fig. Analysis of DEGs and associated pathway terms at timepoint 8 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

(TIF)

S5 Fig. Analysis of DEGs and associated pathway terms at timepoint 16 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

(TIF)

S6 Fig. Analysis of DEGs and associated pathway terms at timepoint 24 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

(TIF)

S7 Fig. Analysis of DEGs and associated pathway terms at timepoint 32 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

(TIF)

S8 Fig. Analysis of DEGs and associated pathway terms at timepoint 40 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

(TIF)

S9 Fig. Analysis of DEGs and associated pathway terms at timepoint 48 hours following.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

(TIF)

S10 Fig. Analysis of DEGs and associated pathway terms at timepoint 60 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

(TIF)

S11 Fig. Analysis of DEGs and associated pathway terms at timepoint 72 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-bipolar paradigm.

(TIF)

S12 Fig. Analysis of DEGs and associated pathway terms at timepoint 96 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms.

(TIF)

S13 Fig. Analysis of DEGs and associated pathway terms at timepoint 144 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod paradigm.

(TIF)

S14 Fig. Analysis of DEGs and associated pathway terms at timepoint 240 hours following Mtz.

(a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

(TIF)

S15 Fig. Immune related terms identified from IPA for NTR-rod early pattern.

(a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-rod early pattern.

(TIF)

S16 Fig. Immune related terms identified from IPA for NTR-bipolar early pattern.

(a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-bipolar early pattern.

(TIF)

S17 Fig. Immune related terms identified from IPA for NTR-rod late pattern.

(a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-rod late pattern.

(TIF)

S18 Fig. Immune related terms identified from IPA for NTR-bipolar late pattern.

(a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-bipolar late pattern.

(TIF)

S19 Fig. Literature search for immune or regeneration related terms.

(a-b) The top ~50–60 DEGs for the NTR-rod (a) and NTR-bipolar (b) patterns were searched in the literature for any links to a role in the immune system or in regeneration. The percentage of those with a link to each term are shown. (c-d) Bar showing the percentage of top DEGs that were implicated in the immune system (c) or regeneration (d).

(TIF)

S20 Fig. Effects on rod cell development and ablation in txn, stat5a/b and c7b crispants.

(a) Quantification of rod cell development pre-ablation by plate reader assay at 5 dpf in wildtype (WT) and MUT larvae for target genes txn, stat5a/b and c7b. (b) Quantification of rod cell ablation following Mtz treatment by plate reader assay at 7 dpf in non-ablated (-Mtz) and ablated controls (+Mtz) and ablated MUT larvae for target genes txn, stat5a/b and c7b. For statistical comparisons, Welch’s one-way ANOVA was followed by student’s t test with Dunnett’s method for multiple comparisons correction. Asterisks indicate the following p-value ranges: * = p<0.05, ** = p<0.01, *** = p<0.001, and **** = p<0.0001, “ns” indicates p>0.05.

(TIF)

S1 Table. mRNA quality of samples collected for microarray analysis.

(XLSX)

S2 Table. qPCR primers used.

(XLSX)

S3 Table. Early pattern genes for bipolar and rod ablation paradigms.

(XLSX)

S4 Table. Late pattern genes for bipolar and rod ablation paradigms.

(XLSX)

S5 Table. Gene Ontology (GO) pathway analysis results for early and late patterns.

(XLSX)

S6 Table. Ingenuity Pathway Analysis (IPA) results for early and late patterns.

(XLS)

S7 Table. All differentially expressed genes identified in NTR:rod paradigm.

(XLSX)

S8 Table. All differentially expressed genes identified in NTR:bipolar paradigm.

(XLSX)

Acknowledgments

We thank BioRender.com for the permission to use scientific icons in making figures.

Data Availability

Raw microarray expression data that support the findings of this study have been deposited in GEO with the accession code GSE234646. Additionally, processed microarray data directly supporting the results in this manuscript (pattern analyses, pathway results and DEGs) can be found in S3S8 Tables.

Funding Statement

This project was funded by the following grant awards: F31-EY032790 from NIH/NEI (KE); T32-EY7143-22 from NIH/NEI (KE); F31-EY021713 from NIH/NEI (SLW); R01-EY022810 from NIH/NEI (JSM); R01-EY033009 from NIH/NEI (JSM); Vision Discovery Institute – Pilot Project from the Medical College of Georgia (JSM); 5-FY10-7 Basil O’Connor Starter Scholar Research Award from the March of Dimes (JSM). Salary support from funders was received by KE (NIH/NEI), SLW (NIH/NEI), and JSM (NIH/NEI March of Dimes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Too LK, Simunovic MP. Retinal Stem/Progenitor Cells Derived From Adult Müller Glia for the Treatment of Retinal Degeneration. Front Cell Dev Biol 2021;9:749131; doi: 10.3389/fcell.2021.749131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lahne M, Nagashima M, Hyde DR, Hitchcock PF. Reprogramming Müller Glia to Regenerate Retinal Neurons. Annu Rev Vis Sci 2020;6:171–193; doi: 10.1146/annurev-vision-121219-081808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lenkowski JR, Raymond PA. Müller glia: Stem cells for generation and regeneration of retinal neurons in teleost fish. Prog Retin Eye Res 2014;40:94–123; doi: 10.1016/j.preteyeres.2013.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ueki Y, Wilken MS, Cox KE, Chipman L, Jorstad N, Sternhagen K, et al. Transgenic expression of the proneural transcription factor Ascl1 in Müller glia stimulates retinal regeneration in young mice. Proc Natl Acad Sci U S A 2015;112(44):13717–13722; doi: 10.1073/pnas.1510595112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jorstad NL, Wilken MS, Grimes WN, Wohl SG, VandenBosch LS, Yoshimatsu T, et al. Stimulation of functional neuronal regeneration from Müller glia in adult mice. Nature 2017;548(7665):103–107; doi: 10.1038/nature23283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jorstad NL, Wilken MS, Todd L, Finkbeiner C, Nakamura P, Radulovich N, et al. STAT Signaling Modifies Ascl1 Chromatin Binding and Limits Neural Regeneration from Muller Glia in Adult Mouse Retina. Cell Rep 2020;30(7):2195–2208.e5; doi: 10.1016/j.celrep.2020.01.075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Todd L, Hooper MJ, Haugan AK, Finkbeiner C, Jorstad N, Radulovich N, et al. Efficient stimulation of retinal regeneration from Müller glia in adult mice using combinations of proneural bHLH transcription factors. Cell Rep 2021;37(3):109857; doi: 10.1016/j.celrep.2021.109857 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yao K, Qiu S, Tian L, Snider WD, Flannery JG, Schaffer DV, et al. Wnt regulates proliferation and neurogenic potential of Müller glial cells through a Lin28/let-7 miRNA-dependent pathway in adult mammalian retina. Cell Rep 2016;17(1):165–178; doi: 10.1016/j.celrep.2016.08.078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Goldman D. Müller glial cell reprogramming and retina regeneration. Nat Rev Neurosci 2014;15(7):431–442; doi: 10.1038/nrn3723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gorsuch R a, Hyde DR. Regulation of Müller glial dependent neuronal regeneration in the damaged adult zebrafish retina. Exp Eye Res 2014;123:131–40; doi: 10.1016/j.exer.2013.07.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Elsaeidi F, Macpherson P, Mills EA, Jui J, Flannery JG, Goldman D. Notch suppression collaborates with Ascl1 and Lin28 to unleash a regenerative response in fish retina, but not in mice. J Neurosci 2018; doi: 10.1523/JNEUROSCI.2126-17.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lahne M, Brecker M, Jones SE, Hyde DR. The Regenerating Adult Zebrafish Retina Recapitulates Developmental Fate Specification Programs. Front Cell Dev Biol 2020;8:617923; doi: 10.3389/fcell.2020.617923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fraser B, DuVal MG, Wang H, Allison WT. Regeneration of Cone Photoreceptors when Cell Ablation Is Primarily Restricted to a Particular Cone Subtype. PLoS ONE 2013; doi: 10.1371/journal.pone.0055410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.D’Orazi FD, Suzuki SC, Darling N, Wong RO, Yoshimatsu T. Conditional and biased regeneration of cone photoreceptor types in the zebrafish retina. J Comp Neurol 2020; doi: 10.1002/cne.24933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ng Chi Kei J, Currie PD, Jusuf PR. Fate bias during neural regeneration adjusts dynamically without recapitulating developmental fate progression. Neural Develop 2017; doi: 10.1186/s13064-017-0089-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.DuVal MG, Allison WT. Impacts of the Retinal Environment and Photoreceptor Type on Functional Regeneration. Neural Regen Res 2017; doi: 10.4103/1673-5374.202930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Braisted JE, Essman TF, Raymond P a. Selective regeneration of photoreceptors in goldfish retina. Dev Camb Engl 1994;120(9):2409–19. doi: 10.1242/dev.120.9.2409 [DOI] [PubMed] [Google Scholar]
  • 18.Vihtelic TS, Hyde DR. Light-Induced Rod and Cone Cell Death and Regeneration in the Adult albino Zebrafish (Danio rerio) Retina ABSTRACT: 2000. [DOI] [PubMed]
  • 19.Thomas JL, Nelson CM, Luo X, Hyde DR, Thummel R. Characterization of multiple light damage paradigms reveals regional differences in photoreceptor loss. Exp Eye Res 2012; doi: 10.1016/j.exer.2012.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Thomas JL, Thummel R. A novel light damage paradigm for use in retinal regeneration studies in adult zebrafish. J Vis Exp JoVE 2013. doi: 10.3791/51017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Maier W, Wolburg H. Regeneration of the Goldfish Retina After Exposure to Different Doses of Ouabain. Cell Tissue Res 1979;118:99–118. doi: 10.1007/BF00239223 [DOI] [PubMed] [Google Scholar]
  • 22.Fimbel SM, Montgomery JE, Burket CT, Hyde DR. Regeneration of inner retinal neurons after intravitreal injection of ouabain in zebrafish. J Neurosci Off J Soc Neurosci 2007;27(7):1712–24; doi: 10.1523/JNEUROSCI.5317-06.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hitchcock PF, Lindsey Myhr KJ, Easter SS, Mangione-Smith R, Jones DD. Local regeneration in the retina of the goldfish. J Neurobiol 1992;23(2):187–203; doi: 10.1002/neu.480230209 [DOI] [PubMed] [Google Scholar]
  • 24.Cameron D a Easter SS. Cone photoreceptor regeneration in adult fish retina: phenotypic determination and mosaic pattern formation. J Neurosci Off J Soc Neurosci 1995;15(3 Pt 2):2255–71. doi: 10.1523/JNEUROSCI.15-03-02255.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Johns PR, Fernald RD. Genesis of rods in teleost fish retina. Nature 1981; doi: 10.1038/293141a0 [DOI] [PubMed] [Google Scholar]
  • 26.Raymond PA, Rivlin PK. Germinal cells in the goldfish retina that produce rod photoreceptors. Dev Biol 1987; doi: 10.1016/0012-1606(87)90338-1 [DOI] [PubMed] [Google Scholar]
  • 27.Wu DM, Schneiderman T, Burgett J, Barthel L, Raymond PA. Cones regenerate from retinal stem cells sequestered in the inner nuclear layer of adult goldfish retina. Invest Ophthalmol Vis Sci 2001;42(9):2115–24. [PubMed] [Google Scholar]
  • 28.Hitchcock PF, Raymond PA. The Teleost Retina as a Model for Developmental and Regeneration Biology. Zebrafish 2004; doi: 10.1089/zeb.2004.1.257 [DOI] [PubMed] [Google Scholar]
  • 29.Hoang T, Wang J, Boyd P, Wang F, Santiago C, Jiang L, et al. Gene regulatory networks controlling vertebrate retinal regeneration. Science 2020;370(6519); doi: 10.1126/science.abb8598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res 1999;18(1):39–57; doi: 10.1016/s1350-9462(98)00014-7 [DOI] [PubMed] [Google Scholar]
  • 31.Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990; doi: 10.1038/343364a0 [DOI] [PubMed] [Google Scholar]
  • 32.Anlezark GM, Melton RG, Sherwood RF, Coles B, Friedlos F, Knox RJ. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I. Purification and properties of a nitroreductase enzyme from Escherichia coli—a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT). Biochem Pharmacol 1992;44(12):2289–95. doi: 10.1016/0006-2952(92)90671-5 [DOI] [PubMed] [Google Scholar]
  • 33.Knox RJ, Friedlos F, Sherwood RF, Melton RG, Anlezark GM. The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—II. A comparison of an Escherichia coli nitroreductase and Walker DT diaphorase. Biochem Pharmacol 1992;44(12):2297–301. doi: 10.1016/0006-2952(92)90672-6 [DOI] [PubMed] [Google Scholar]
  • 34.Sunters A, Baer J, Bagshawe KD. Cytotoxicity and activation of CB1954 in a human tumour cell line. Biochem Pharmacol 1991;41(9):1293–8. doi: 10.1016/0006-2952(91)90100-j [DOI] [PubMed] [Google Scholar]
  • 35.Williams EM, Little RF, Mowday AM, Rich MH, Chan-Hyams JV, Copp JN, et al. Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility. Biochem J 2015;471(2):131–153; doi: 10.1042/BJ20150650 [DOI] [PubMed] [Google Scholar]
  • 36.Bridgewater JA, Springer CJ, Knox RJ, Minton NP, Michael NP, Collins MK. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. Eur J Cancer Oxf Engl 1990 1995;31A(13–14):2362–2370; doi: 10.1016/0959-8049(95)00436-x [DOI] [PubMed] [Google Scholar]
  • 37.White DT, Mumm JS. The nitroreductase system of inducible targeted ablation facilitates cell-specific regenerative studies in zebrafish. Methods 2013;62(3):232–240; doi: 10.1016/j.ymeth.2013.03.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mathias JR, Zhang Z, Saxena MT, Mumm JS. Enhanced cell-specific ablation in zebrafish using a triple mutant of escherichia coli nitroreductase. Zebrafish 2014; doi: 10.1089/zeb.2013.0937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.White DT, Sengupta S, Saxena MT, Xu Q, Hanes J, Ding D, et al. Immunomodulation-accelerated neuronal regeneration following selective rod photoreceptor cell ablation in the zebrafish retina. Proc Natl Acad Sci U S A 2017; doi: 10.1073/pnas.1617721114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.White DT, Eroglu AU, Wang G, Zhang L, Sengupta S, Ding D, et al. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates. Nat Protoc 2016;11(12):2432–2453; doi: 10.1038/nprot.2016.142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zhang L, Chen C, Fu J, Lilley B, Berlinicke C, Hansen B, et al. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa. eLife 2021;10:e57245; doi: 10.7554/eLife.57245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sharrock AV, Mulligan TS, Hall KR, Williams EM, White DT, Zhang L, et al. NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation. Nat Methods 2022;19(2):205–215; doi: 10.1038/s41592-021-01364-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Curado S, Anderson RM, Jungblut B, Mumm J, Schroeter E, Stainier DY. Conditional targeted cell ablation in zebrafish: A new tool for regeneration studies. Dev Dyn 2007; doi: 10.1002/dvdy.21100 [DOI] [PubMed] [Google Scholar]
  • 44.Pisharath H, Rhee JM, Swanson M a, Leach SD, Parsons MJ. Targeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli nitroreductase. Mech Dev 2007;124(3):218–29; doi: 10.1016/j.mod.2006.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ariga J, Walker SL, Mumm JS. Multicolor time-lapse imaging of transgenic zebrafish: visualizing retinal stem cells activated by targeted neuronal cell ablation. J Vis Exp JoVE 2010;(43):2–7; doi: 10.3791/2093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Walker SL, Ariga J, Mathias JR, Coothankandaswamy V, Xie X, Distel M, et al. Automated reporter quantification in vivo: High-throughput screening method for reporter-based assays in zebrafish. PLoS ONE 2012;7(1):e29916; doi: 10.1371/journal.pone.0029916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Perkins BD. Zebrafish models of inherited retinal dystrophies. J Transl Genet Genomics 2022;6(1):95–110; doi: 10.20517/jtgg.2021.47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Schroeter EH, Wong ROL, Gregg RG. In vivo development of retinal ON-bipolar cell axonal terminals visualized in nyx::MYFP transgenic zebrafish. Vis Neurosci 2006;23(5):833–43; doi: 10.1017/S0952523806230219 [DOI] [PubMed] [Google Scholar]
  • 49.Hamaoka T, Takechi M, Chinen A, Nishiwaki Y, Kawamura S. Visualization of rod photoreceptor development using GFP-transgenic zebrafish. Genesis 2002;34(3):215–20; doi: 10.1002/gene.10155 [DOI] [PubMed] [Google Scholar]
  • 50.Schmitt EA, Dowling JE. Comparison of topographical patterns of ganglion and photoreceptor cell differentiation in the retina of the zebrafish, Danio rerio. J Comp Neurol 1996; doi: [DOI] [PubMed] [Google Scholar]
  • 51.Larison KD, Bremiller R. Early onset of phenotype and cell patterning in the embryonic zebrafish retina. Development 1990. doi: 10.1242/dev.109.3.567 [DOI] [PubMed] [Google Scholar]
  • 52.Vihtelic TS, Doro CJ, Hyde DR. Cloning and characterization of six zebrafish photoreceptor opsin cDNAs and immunolocalization of their corresponding proteins. Vis Neurosci 1999; doi: 10.1017/s0952523899163168 [DOI] [PubMed] [Google Scholar]
  • 53.Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; doi: 10.1083/jcb.119.3.493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Montgomery JE, Parsons MJ, Hyde DR. A novel model of retinal ablation demonstrates that the extent of rod cell death regulates the origin of the regenerated zebrafish rod photoreceptors. J Comp Neurol 2010;518(6):800–814; doi: 10.1002/cne.22243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Meyers JR, Hu L, Moses A, Kaboli K, Papandrea A, Raymond PA. β-catenin/Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina. Neural Develop 2012;7:30; doi: 10.1186/1749-8104-7-30 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Smith CJ, Osborn AM. Advantages and limitations of quantitative PCR (Q-PCR)-based approaches in microbial ecology. FEMS Microbiol Ecol 2009;67(1):6–20; doi: 10.1111/j.1574-6941.2008.00629.x [DOI] [PubMed] [Google Scholar]
  • 57.Ulgen E, Ozisik O, Sezerman OU. pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks. Front Genet 2019;10:858; doi: 10.3389/fgene.2019.00858 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Emmerich K, White DT, Kambhampati SP, Casado GL, Fu TM, Chunawala Z, et al. Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina. Commun Biol 2023;6(1):1–14; doi: 10.1038/s42003-023-04898-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Wu RS, Lam II, Clay H, Duong DN, Deo RC, Coughlin SR. A Rapid Method for Directed Gene Knockout for Screening in G0 Zebrafish. Dev Cell 2018;46(1):112–125.e4; doi: 10.1016/j.devcel.2018.06.003 [DOI] [PubMed] [Google Scholar]
  • 60.Fausett B V., Gumerson JD, Goldman D. The proneural basic helix-loop-helix gene Ascl1a is required for retina regeneration. J Neurosci 2008; doi: 10.1523/JNEUROSCI.4853-07.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gorsuch RA, Lahne M, Yarka CE, Petravick ME, Li J, Hyde DR. Sox2 regulates Müller glia reprogramming and proliferation in the regenerating zebrafish retina via Lin28 and Ascl1a. Exp Eye Res 2017; doi: 10.1016/j.exer.2017.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Nelson CM, Gorsuch RA, Bailey TJ, Ackerman KM, Kassen SC, Hyde DR. Stat3 defines three populations of müller glia and is required for initiating maximal müller glia proliferation in the regenerating zebrafish retina. J Comp Neurol 2012; doi: 10.1002/cne.23213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Powell C, Cornblath E, Elsaeidi F, Wan J, Goldman D. Zebrafish Müller glia-derived progenitors are multipotent, exhibit proliferative biases and regenerate excess neurons. Sci Rep 2016;6:24851; doi: 10.1038/srep24851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Xiao D, Qiu S, Huang X, Zhang R, Lei Q, Huang W, et al. Directed robust generation of functional retinal ganglion cells from Müller glia. bioRxiv 2019;735357; doi: 10.1101/735357 [DOI] [Google Scholar]
  • 65.Todd L, Jenkins W, Finkbeiner C, Hooper MG, Donaldson PC, Pavlou M, et al. Reprogramming Müller glia to regenerate ganglion-like cells in adult mouse retina with developmental transcription factors. Sci Adv 2022;8(47):eabq7219; doi: 10.1126/sciadv.abq7219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Krylov AJ, Yu S, Veen K, Newton A, Ye A, Qin H, et al. Heterogeneity in Quiescent Müller Glia in the Uninjured Zebrafish Retina Drive Differential Responses Following Photoreceptor Ablation. 2023;2023.01.27.525802; doi: 10.1101/2023.01.27.525802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Sifuentes CJ, Kim JW, Swaroop A, Raymond PA. Rapid, dynamic activation of Müller Glial stem cell responses in Zebrafish. Invest Ophthalmol Vis Sci 2016;57(13):5148–5160; doi: 10.1167/iovs.16-19973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Morris AC, Forbes-Osborne MA, Pillai LS, Fadool JM. Microarray analysis of XOPS-mCFP zebrafish retina identifies genes associated with rod photoreceptor degeneration and regeneration. Invest Ophthalmol Vis Sci 2011; doi: 10.1167/iovs.10-6022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Yurco P, Cameron DA. Cellular correlates of proneural and notch-delta gene expression in the regenerating zebrafish retina. Vis Neurosci 2007;24(3):437–443; doi: 10.1017/S0952523807070496 [DOI] [PubMed] [Google Scholar]
  • 70.Kassen SC, Ramanan V, Montgomery JE, Burket CT, Liu C, Vihtelic TS, et al. Time course analysis of gene expression during light-induced photoreceptor cell death and regeneration in albino zebrafish. Dev Neurobiol 2007; doi: 10.1002/dneu.20362 [DOI] [PubMed] [Google Scholar]
  • 71.Ramachandran R, Zhao X-F, Goldman D. Insm1a-mediated gene repression is essential for the formation and differentiation of Müller glia-derived progenitors in the injured retina. Nat Cell Biol 2012;14(10):1013–1023; doi: 10.1038/ncb2586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Cameron DA, Gentile KL, Middleton FA, et al. Gene expression profiles of intact and regenerating zebrafish retina. Mol Vis 2005;11:775–791. [PubMed] [Google Scholar]
  • 73.Sahu A, Devi S, Jui J, Goldman D. Notch signaling via Hey1 and Id2b regulates Müller glia’s regenerative response to retinal injury. Glia 2021;69(12):2882–2898; doi: 10.1002/glia.24075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Zhang Z, Hou H, Yu S, Zhou C, Zhang X, Li N, et al. Inflammation-induced mammalian target of rapamycin signaling is essential for retina regeneration. Glia 2020;68(1):111–127; doi: 10.1002/glia.23707 [DOI] [PubMed] [Google Scholar]
  • 75.Jeong EM, Yoon J-H, Lim J, Shin J-W, Cho AY, Heo J, et al. Real-Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function. Stem Cell Rep 2018;10(2):600–614; doi: 10.1016/j.stemcr.2017.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Ludikhuize MC, Rodríguez Colman MJ. Metabolic Regulation of Stem Cells and Differentiation: A Forkhead Box O Transcription Factor Perspective. Antioxid Redox Signal 2021;34(13):1004–1024; doi: 10.1089/ars.2020.8126 [DOI] [PubMed] [Google Scholar]
  • 77.Ogrodnik M, Zhu Y, Langhi LGP, Tchkonia T, Krüger P, Fielder E, et al. Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis. Cell Metab 2019;29(5):1233; doi: 10.1016/j.cmet.2019.01.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Saul KE, Koke JR, García DM. Activating transcription factor 3 (ATF3) expression in the neural retina and optic nerve of zebrafish during optic nerve regeneration. Comp Biochem Physiol A Mol Integr Physiol 2010;155(2):172–182; doi: 10.1016/j.cbpa.2009.10.042 [DOI] [PubMed] [Google Scholar]
  • 79.Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kitaoka T, et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996; doi: 10.1002/j.1460-2075.1996.tb00734.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Luzio A, Figueiredo M, Matos MM, Coimbra AM, Álvaro AR, Monteiro SM. Effects of short-term exposure to genistein and overfeeding diet on the neural and retinal progenitor competence of adult zebrafish (Danio rerio). Neurotoxicol Teratol 2021;88:107030; doi: 10.1016/j.ntt.2021.107030 [DOI] [PubMed] [Google Scholar]
  • 81.Hagemeyer N, Prinz M. Burning down the house: IRF7 makes the difference for microglia. EMBO J 2014;33(24):2885–2886; doi: 10.15252/embj.201490345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Cohen M, Matcovitch O, David E, Barnett-Itzhaki Z, Keren-Shaul H, Blecher-Gonen R, et al. Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. EMBO J 2014;33(24):2906–2921; doi: 10.15252/embj.201489293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Emmerich KB, White DT, Kambhampati SP, Lee GY, Fu TM, Sahoo A, et al. Dendrimer-targeted immunosuppression of microglia reactivity super-accelerates photoreceptor regeneration in the zebrafish retina. bioRxiv 2021;2020.08.05.238352; doi: 10.1101/2020.08.05.238352 [DOI] [Google Scholar]
  • 84.Fukada T. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 1998; doi: 10.1093/emboj/17.22.6670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Yamashita S, Miyagi C, Carmany-Rampey A, Shimizu T, Fujii R, Schier AF, et al. Stat3 controls cell movements during zebrafish gastrulation. Dev Cell 2002; doi: 10.1016/s1534-5807(02)00126-0 [DOI] [PubMed] [Google Scholar]
  • 86.Avalle L, Pensa S, Regis G, Novelli F, Poli V. STAT1 and STAT3 in tumorigenesis: A matter of balance. JAK-STAT 2012; doi: 10.4161/jkst.20045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Hutchins AP, Diez D, Miranda-Saavedra D. The IL-10/STAT3-mediated anti-inflammatory response: Recent developments and future challenges. Brief Funct Genomics 2013; doi: 10.1093/bfgp/elt028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Carballo M, Conde M, El Bekay R, Martín-Nieto J, Camacho MJ, Monteseirín J, et al. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 1999; doi: 10.1074/jbc.274.25.17580 [DOI] [PubMed] [Google Scholar]
  • 89.Zhao Q, Cheng X, Guo J, Bi Y, Kuang L, Ren J, et al. MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway. Int J Biol Sci 2021;17(3):869–881; doi: 10.7150/ijbs.56152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Zhao Q, Guo J, Cheng X, Liao Y, Bi Y, Gong Y, et al. RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis. Front Oncol 2021;11:664927; doi: 10.3389/fonc.2021.664927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Smith AD, Lu C, Payne D, Paschall AV, Klement JD, Redd PS, et al. Autocrine IL6-mediated activation of the STAT3-DNMT axis silences the TNFα-RIP1 necroptosis pathway to sustain survival and accumulation of myeloid-derived suppressor cells. Cancer Res 2020;80(15):3145–3156; doi: 10.1158/0008-5472.CAN-19-3670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Jiang L, Zhao X-H, Mao Y-L, Wang J-F, Zheng H-J, You Q-S. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6. J Exp Clin Cancer Res CR 2019;38:465; doi: 10.1186/s13046-019-1428-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Thanasaksiri K, Hirono I, Kondo H. Identification and expression analysis of suppressors of cytokine signaling (SOCS) of Japanese flounder Paralichthys olivaceus. Fish Shellfish Immunol 2016; doi: 10.1016/j.fsi.2016.09.018 [DOI] [PubMed] [Google Scholar]
  • 94.Liang J, Wang D, Renaud G, Wolfsberg TG, Wilson AF, Burgess SM. The stat3/socs3a pathway is a key regulator of hair cell regeneration in zebrafish. J Neurosci 2012; doi: 10.1523/JNEUROSCI.5785-10.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Khaliq M, Ko S, Liu Y, Wang H, Sun Y, Solnica-Krezel L, et al. Stat 3 regulates liver progenitor cell-driven liver regeneration in zebrafish. Gene Expr 2018; doi: 10.3727/105221618X15242506133273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489(7414):57–74; doi: 10.1038/nature11247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Silva NJ, Nagashima M, Li J, Kakuk-Atkins L, Ashrafzadeh M, Hyde DR, et al. Inflammation and matrix metalloproteinase 9 (Mmp-9) regulate photoreceptor regeneration in adult zebrafish. Glia 2020;68(7):1445–1465; doi: 10.1002/glia.23792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Köster RW, Fraser SE. Tracing transgene expression in living zebrafish embryos. Dev Biol 2001;233(2):329–46; doi: 10.1006/dbio.2001.0242 [DOI] [PubMed] [Google Scholar]
  • 99.Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, et al. Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 2000; doi: 10.1038/81619 [DOI] [PubMed] [Google Scholar]
  • 100.Pusch CM, Zeitz C, Brandau O, Pesch K, Achatz H, Feil S, et al. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet 2000; doi: 10.1038/81627 [DOI] [PubMed] [Google Scholar]
  • 101.Davison JM, Akitake CM, Goll MG, Rhee JM, Gosse N, Baier H, et al. Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish. Dev Biol 2007;304(2):811–24; doi: 10.1016/j.ydbio.2007.01.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Godinho L, Mumm JS, Williams PR, Schroeter EH, Koerber A, Park SW, et al. Targeting of amacrine cell neurites to appropriate synaptic laminae in the developing zebrafish retina. Development 2005;132(22):5069–79; doi: 10.1242/dev.02075 [DOI] [PubMed] [Google Scholar]
  • 103.D’Agati G, Beltre R, Sessa A, Burger A, Zhou Y, Mosimann C, et al. A defect in the mitochondrial protein Mpv17 underlies the transparent casper zebrafish. Dev Biol 2017;430(1):11–17; doi: 10.1016/j.ydbio.2017.07.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Ren JQ, McCarthy WR, Zhang H, Adolph AR, Li L. Behavioral visual responses of wild-type and hypopigmented zebrafish. Vision Res 2002;42(3):293–9. doi: 10.1016/s0042-6989(01)00284-x [DOI] [PubMed] [Google Scholar]
  • 105.Mumm JS, Williams PR, Godinho L, Koerber A, Pittman AJ, Roeser T, et al. In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells. Neuron 2006;52(4):609–21; doi: 10.1016/j.neuron.2006.10.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;7(1):3; doi: 10.1186/1471-2199-7-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Reimers M, Carey VJ. [8] Bioconductor: An Open Source Framework for Bioinformatics and Computational Biology. Methods Enzymol 2006; doi: 10.1016/S0076-6879(06)11008-3 [DOI] [PubMed] [Google Scholar]
  • 108.Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 2006; doi: 10.1186/1471-2164-7-252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z. CARMAweb: Comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res 2006; doi: 10.1093/nar/gkl038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Hochreiter S, Clevert DA, Obermayer K. A new summarization method for affymetrix probe level data. Bioinformatics 2006; doi: 10.1093/bioinformatics/btl033 [DOI] [PubMed] [Google Scholar]
  • 111.Freue GVC, Hollander Z, Shen E, Zamar RH, Balshaw R, Scherer A, et al. MDQC: A new quality assessment method for microarrays based on quality control reports. Bioinformatics 2007; doi: 10.1093/bioinformatics/btm487 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Gregory S Barsh

21 Mar 2023

Dear Dr Mumm,

Thank you very much for submitting your Research Article entitled 'Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Gregory Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In the article by Emmerich, et al., the Authors leverage prior technologies created in the laboratory of Dr. Mumm to investigate transcriptomic changes across the regeneration of the zebrafish retina in two different, cell type-specific ablation paradigms. This work assesses the functional consequence of loss of individual cell fates, serving as a proxy to degenerations that affect the human retina and providing insights into the gene regulatory networks that promote cell-type specific regeneration in zebrafish and/or limit the regenerative ability of the human retina.

The manuscript does a good job of providing details of background and rationale for the studies, technologies utilized, interpretations of transcriptomic and pathway analyses, and providing context of the discoveries within prior research.

Additionally, the Authors provide biological relevance for findings of stat3 differential expression.

Areas to be addressed:

Minor Points:

1) Fig. 1 - l and m - please label the figure with the treatment paradigm that each panel represents

2) Statistics:

- All figures with statistical analyses: please provide the statistical test utilized for each analysis within the figure legend where statistical data is presented. It is unclear which panels utilized t-tests versus One-way ANOVAs based on the presented data/methods

- no statistics on figure 6 c

- line 230-233 - the authors make comparisons between differences in location of proliferative cells between rod and bipolar ablation paradigms. However, no such statistical comparison is actually presented.

- Appropriateness of the statistical methods utilized. Please provide rationale for the use One-Way ANOVA (Figure 1l-m; Figure 6 i). In these analyses, the effect of 2 different variables is being tested; either Region (rod precursor or Muller glia proliferation) and MTZ treatment (Figure 1); or Region (rod precursor or Muller glia proliferation) and stat3 expression (Figure 6). It seems like a two-way ANOVA would be more appropriate.

3) KEGG pathway analyses would be more informative if data was presented with up- and down-regulated genes separated. For example, in Supp. Fig 4C - KEGG pathway analysis of ALL differential genes shows an 'enrichment' of phototransduction genes. It would be more informative if all down-regulated genes were analyzed indepedently of 'up-regulated' genes and 'phototransduction' was significantly enriched, consistent with loss of rod photoreceptors. Analyzing both up and down-regulated genes together may actually be reducing the significance of pathways that are affected.

4) Data availability - Unclear if the Microarray data has been submitted to a publicly available resources (GEO)

Major Point:

The goal of the study is to provide evidence of differential regenerative responses at the transcriptomic level based on specific cell type ablation paradigms. This goal is met through the comprehensive microarray analyses. However the biological relevance of these findings remains limited.

stat3 has already been implicated in regulating regenerative responses in both fish and mice, a finding acknowledged by the Authors with appropriate references. To achieve a goal of identifying cell type-specific ablation responses, the authors would provide one or both of the following:

1) Proliferative response in bipolar ablation paradigm with/without loss of stat3; direct comparisons to rod ablation response. If stat3 is most important for Muller glia-derived regeneration, one may anticipate a more drastic inhibition of bipolar cell regeneration. An observation of no-difference compared to rod-ablation would suggest that stat3 is required for both rod precursor and Muller glia-derived regeneration, supporting the transcriptomic data where stat3-signaling was affected in both paradigms

2) Examination of the regenerative responses when a bipolar-cell ablation 'hub' gene is reduced (PPARG), in both the rod and bipolar ablation paradigms. The differential activity of the KEGG pathway analyses might suggest differential response.

It should be noted that any result from either/both of these suggested experiments would be informative.

Reviewer #2: Kevin Emmerich and colleagues use microarray transriptomics to characterize homogenates of eye tissue in a time-course study where wither rods were ablated (rod-NTR) or a small subset of bipolar cells were ablated (bipolar-NTR). The responses of the transcriptome were different. Some surprises in the data were that these differences began immediately, which the authors interpret as differences in fate-choice. Some softening of that interpretation (offering alternatives) is suggested below.

Considering the potential for stem-cell-based regenerative therapies in blindness (which is the most likely pioneer for such treatments of other neurodegenerative diseases), the massive data sets produced here are an excellent resource for the community. Their comparative framing (between regeneration paradigms, across time) adds considerably to their anticipated power. It is reasonable to expect that mining these data sets will influence future researchers as they seek to implement plans to therapeutically regenerate cells.

If the work to be repeated today it would consider single cell transcriptomics and allow an additional depth of information, but the data provided here are valuable nonetheless. Some ideas about the manuscript appear below, focussed on alternative interpretations the authors might wish to consider.

1) Line 148 & opening of Discussion & closing of Discussion (line 707), regarding the suggestion that the type of cell loss informs the MG stem cell activation via altering *cell-fate* choices. The writing seems to have an unstated assumption that only one population of MG stem cells is present, and only one population is activated regardless of ablation paradigm, and thus the differential outcomes thus must result from differential fate choices. It is important to forthrightly consider an alternative interpretation that multiple populations of stem cells exist, and actually your paradigms are triggering different ones, thereby producing distinct gene abundances at initiation. The wording in abstract (line 49, 57) seems more appropriate, i.e. agnostic to ‘how’ the response is different, and instead identifying that it is different.

a. Data in Fig 1 (described in lines 227-238) undercut the interpretation that differences in the response are based in cell fate choices, an interpretation that would require the same stem cell population to be activated towards two different states. Instead, what is happening here is that two different stem cell populations are activated. [still very interesting, but must be interpreted with care; and the Rationale that the data give you instructions to replace a particular cell type then seems confounded too]

2) Discussion should be forthright in describing alternative reasons why one might observe differential responses other than just a difference between cell types being ablated.

a. E.g. a technical artefact could arise if the two lines have different NTR amount or different NTR intracellular-localization, or presence/absence of Gal4-VP16 – any of these could alter the quality of cell death and signals produced even within a given cell type.

b. The impact of ablating ~hundred cells vs. thousands of cells (in bipolar vs. rod lines) would be expected to be substantial.

c. Moreover, the random insertion of multiple transgenes differs in the two lines (and likely includes many haplotype differences dragged along with the transgenes in the two lines) such that the genetic background of the compared fish is probably quite different [consider that the standard in mice is to now compare multiple isogenic lines for any transgenic-based phenotype].

d. It is also possible that the peak of cell death might be offset by several hours in one line vs. the other, due to the Tg or the inherent resilience of the cells, and so the responses would occur in distinct time bins within the circadian cycle.

3) The beginning of the Results has a focus on specificity of the induced cell death (e.g. line 155). The compelling data to challenge this claim must exist within the transcriptomic data sets. E.g. rod opsin and transduction machinery ought to be reduced in abundance for the NTR-rod line compared to controls and compared to the NTR-bipolar line. Bipolar-specific genes should show the opposite pattern. A comment on this seems worth including in this early section of the Results (even if it is to offer the logic and send the reader to later data).

a. This is alluded to later (line 430) but not with enough detail to serve the purpose requested here. What are some examples of genes and what is their differential abundance? [image resolution in Fig 3b-h is poor, and I cannot read any gene names]

4) Approriate validation of this transciptomics approach, considering the presented rationale, would be to show therapeutic potential – i.e. that providing one of the DEG is sufficient to enhance the regeneration. Instead, the authors chose to demonstrate that a DEG, stat3, is required for regeneration. Thus the path to translation has not been clearly established here, though the data is undoubtedly of theoretical interest for that purpose.

Minor suggestions:

a) I’m baffled by how the in vivo imaging was accomplished (it is excellent). How does one image through a pigmented eye in a living 11 dpf zebrafish? (roy mutants are still pigmented). I could not find any of this in the Methods or associated Results near description of Figure 1.

b) where does the CFP in your images come from (Fig 1 legend should indicate this).

c) Line 35 ‘in’ s/b ‘and’

d) Line 70 you implicate immune-related genes, not the immune system itself. It’s only “the immune system” if you accept the over-simplistic assumptions of a KEGG pathway as top-line gene function assignments. “strongly implicated” seems too strong with the adjacent current wording. But I think the authors can be given licence to interpret their data as they prefer, where it is obvious that it is interpretation-not-statement-of-fact.

e) Related to above comment – line 514: is 38% and 44% an impressive number? I think most any DEG data set might show a similar type of abundance of genes related to the immune system. What if you compare the control fish from 6dpf and 11 dpf, is the abundance of these ‘immune-related genes’ <25%? Maybe not an analysis worth doing, but I think you could soften your language: you’ll always find these associations if you go looking for them.

f) Line 117, (& 149, 61, 588). “Retinal degenerative diseases typically involve the loss of discrete cell types.” A version of this statement was made earlier too – it seems a bit simple, self-serving, and certainly needs some references and examples. E.g. many blinding disorders involve loss of function mutations that may not (for many years) lead to cell loss (maybe they produce dysmorphic cells). Are there prominent examples of disorders where bipolar cells are suddenly lost? To be more optimistic in my comment, learning how to regenerate a rod photoreceptor is valuable as an imagined therapy for many many forms of blindness, including those where more-than-rods are dying. So it seems like the writing leans on this rationale too hard.

g) Line 184 delete ‘selective’. Nothing here demonstrates the ablation is selective (i.e. maybe other cells are killed too).

h) Line 197 to allow Figures to be interpretable as stand-alone items, define and/or explain “NTR”.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: No: Authors describe this in the future tense: "Raw transcriptomic data **will** be made available in a repository before publication"

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Decision Letter 1

Gregory S Barsh

18 Jul 2023

Dear Dr Mumm,

Thank you very much for submitting your Research Article entitled 'Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses' to PLOS Genetics.

The revised manuscript was seen by the previous reviewers, both of whom are positive. There are some remaining concerns raised by reviewer #1 (below) that we ask you address in a hopefully final round of minor revision that will not necessarily require additional external review. 

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Gregory S. Barsh

Editor-in-Chief

PLOS Genetics

Gregory Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have sufficiently addressed the previous critiques. However, there are two areas of the manuscript that need to be addressed:

1) “In contrast, bipolar loss led solely to increased INL proliferation” – statistics don’t support this conclusion; only indicate that total proliferation is increased. INL proliferation is listed as 'ns' compared to control

2) CRISPants (Figure 7). While the inclusion of this data was recognized as a response to both reviewers, the data do not fully support the Authors' conclusions as presented. The Authors state that "Of the six factors tested (Fig. 7b-c), mutation of three led to enhanced rod regeneration (from least to greatest effect: txn (+70%), stat5a/b +85%), and c7b (+96%), while three had no statistically significant effect (nfia, pparg, prdm1a)" compared to WT animals. While txn, stat5a/b and c7b MUT crispants do seem to have an increase in NTR:YFP compared to WT, other possible explanations need to be addressed. Are rod cell numbers equivalent at the start of the injury paradigm in each mutant condition? Are rod cells more resistant to MTZ-mediated cell death when these specific genes are mutated? Other more nuanced scenarios could also explain the observed results. The Authors should at least examine the effect of each mutation on general retinal development (as they are germline mutations) and acknowledge alternative mechanisms exist that lead to what the Authors interpret as 'enhanced regeneration'.

Reviewer #2: I think this is the best job of addressing Reviewer comments I have seen. Congrats to all the authors on a great contribution!

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Brian S Clark

Reviewer #2: No

Decision Letter 2

Gregory S Barsh

7 Aug 2023

Dear Dr Mumm,

We are pleased to inform you that your manuscript entitled "Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Gregory S. Barsh

Editor-in-Chief

PLOS Genetics

Gregory Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-23-00153R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory S Barsh

6 Oct 2023

PGENETICS-D-23-00153R2

Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses

Dear Dr Mumm,

We are pleased to inform you that your manuscript entitled "Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Confirmation of NTR-rod transgene specificity.

    (a-a”) Histological staining in the NTR-rod model showing transgenic Rho:YFP-NTR expression (green) along with antibody staining for rod outer segment marker Zpr-3 (purple). (b-b”) Histological staining in the NTR-rod model showing transgenic Rho:YFP-NTR expression (green) along with antibody staining for cone marker Zpr-1 (purple).

    (TIF)

    S2 Fig. Additional in vivo imaging and TUNEL/PCNA histological imaging.

    (a-b series) In vivo time-series imaging following NTR-rod larvae that were uninjured (a-a”) or received Mtz (b-b”). Images were taken in the same fish at 6 dpf (before Mtz onset in +Mtz larvae), 7 dpf (after Mtz removal) and 11 dpf (following recovery). (c-d series) In vivo time-series imaging following NTR-bipolar larvae that were uninjured (c-c”) or received Mtz (d-d”). Images were taken in the same fish at 6 dpf (before Mtz onset in +Mtz larvae), 7 dpf (after Mtz removal) and 11 dpf (following recovery). Larvae for each ablation paradigm express CFP derived from Tg(pax6-DF4:gap43-CFP)q01 to label general retinal structures (a-d series). (e-f series) Histological staining in uninjured and +Mtz eyes at 7 dpf for TUNEL in the NTR-bipolar (e-e’) and NTR-rod (f-f’) paradigms. (g-h series) Histological staining in uninjured and +Mtz eyes at 9 dpf for PCNA in the NTR-bipolar (g-g’) and NTR-rod (h-h’) paradigms.

    (TIF)

    S3 Fig. qRT-PCR validation of mRNA expression changes.

    (a, b) A subset of tested genes were selected for validation using quantitative Reverse Transcription–Polymerase Chain Reaction (qRT-PCR). 8 genes were selected for a temporal analysis from 0-72h post Mtz in either the NTR-rod (A) or NTR-bipolar (B) paradigm with beta actin serving as a control.

    (TIF)

    S4 Fig. Analysis of DEGs and associated pathway terms at timepoint 8 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

    (TIF)

    S5 Fig. Analysis of DEGs and associated pathway terms at timepoint 16 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

    (TIF)

    S6 Fig. Analysis of DEGs and associated pathway terms at timepoint 24 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

    (TIF)

    S7 Fig. Analysis of DEGs and associated pathway terms at timepoint 32 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

    (TIF)

    S8 Fig. Analysis of DEGs and associated pathway terms at timepoint 40 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

    (TIF)

    S9 Fig. Analysis of DEGs and associated pathway terms at timepoint 48 hours following.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

    (TIF)

    S10 Fig. Analysis of DEGs and associated pathway terms at timepoint 60 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms as well as those shared between the two paradigms.

    (TIF)

    S11 Fig. Analysis of DEGs and associated pathway terms at timepoint 72 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-bipolar paradigm.

    (TIF)

    S12 Fig. Analysis of DEGs and associated pathway terms at timepoint 96 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms.

    (TIF)

    S13 Fig. Analysis of DEGs and associated pathway terms at timepoint 144 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod paradigm.

    (TIF)

    S14 Fig. Analysis of DEGs and associated pathway terms at timepoint 240 hours following Mtz.

    (a) Volcano plot showing the identified up (orange) and down (blue) DEGs in both NTR-rod and NTR-bipolar treatment paradigms. (b) Venn diagram showing the unique as well as shared (and % of shared) DEGs between the two paradigms. (c) KEGG pathfindR identified significantly enriched pathways in the NTR-rod and NTR-bipolar paradigms.

    (TIF)

    S15 Fig. Immune related terms identified from IPA for NTR-rod early pattern.

    (a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-rod early pattern.

    (TIF)

    S16 Fig. Immune related terms identified from IPA for NTR-bipolar early pattern.

    (a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-bipolar early pattern.

    (TIF)

    S17 Fig. Immune related terms identified from IPA for NTR-rod late pattern.

    (a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-rod late pattern.

    (TIF)

    S18 Fig. Immune related terms identified from IPA for NTR-bipolar late pattern.

    (a-d) IPA was used to test for enriched immune related pathway terms from DEGs for the NTR-bipolar late pattern.

    (TIF)

    S19 Fig. Literature search for immune or regeneration related terms.

    (a-b) The top ~50–60 DEGs for the NTR-rod (a) and NTR-bipolar (b) patterns were searched in the literature for any links to a role in the immune system or in regeneration. The percentage of those with a link to each term are shown. (c-d) Bar showing the percentage of top DEGs that were implicated in the immune system (c) or regeneration (d).

    (TIF)

    S20 Fig. Effects on rod cell development and ablation in txn, stat5a/b and c7b crispants.

    (a) Quantification of rod cell development pre-ablation by plate reader assay at 5 dpf in wildtype (WT) and MUT larvae for target genes txn, stat5a/b and c7b. (b) Quantification of rod cell ablation following Mtz treatment by plate reader assay at 7 dpf in non-ablated (-Mtz) and ablated controls (+Mtz) and ablated MUT larvae for target genes txn, stat5a/b and c7b. For statistical comparisons, Welch’s one-way ANOVA was followed by student’s t test with Dunnett’s method for multiple comparisons correction. Asterisks indicate the following p-value ranges: * = p<0.05, ** = p<0.01, *** = p<0.001, and **** = p<0.0001, “ns” indicates p>0.05.

    (TIF)

    S1 Table. mRNA quality of samples collected for microarray analysis.

    (XLSX)

    S2 Table. qPCR primers used.

    (XLSX)

    S3 Table. Early pattern genes for bipolar and rod ablation paradigms.

    (XLSX)

    S4 Table. Late pattern genes for bipolar and rod ablation paradigms.

    (XLSX)

    S5 Table. Gene Ontology (GO) pathway analysis results for early and late patterns.

    (XLSX)

    S6 Table. Ingenuity Pathway Analysis (IPA) results for early and late patterns.

    (XLS)

    S7 Table. All differentially expressed genes identified in NTR:rod paradigm.

    (XLSX)

    S8 Table. All differentially expressed genes identified in NTR:bipolar paradigm.

    (XLSX)

    Attachment

    Submitted filename: 20230621_PlosGeneticsReviewerResponse_ToSUBMIT.docx

    Attachment

    Submitted filename: 20230727_PlosGeneticsReviewerResponse_ToSUBMIT.docx

    Data Availability Statement

    Raw microarray expression data that support the findings of this study have been deposited in GEO with the accession code GSE234646. Additionally, processed microarray data directly supporting the results in this manuscript (pattern analyses, pathway results and DEGs) can be found in S3S8 Tables.


    Articles from PLOS Genetics are provided here courtesy of PLOS

    RESOURCES